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ABSTRACT 
Basic fibroblast growth factor (FGF-2) is a trophic molecule involved in a number of 
functions within the central nervous system (CNS), including a prominent role in the 
regulation of CNS responses to injury. Prior studies suggest that rats recover differently 
from injury inflicted to different regions and at different ages throughout development, 
and that FGF-2 might underlie this phenomenon. This thesis examined whether the 
functional and structural outcome following bilateral injury to the motor cortex inflicted 
at postnatal day (P10) could be ameliorated by exogenous administration of a growth 
factor (FGF-2). Four complimentary studies were conducted that each assessed the role 
of FGF-2 in mediating recovery from bilateral motor cortex injury inflicted at P10. We 
found that FGF-2 improves physiological, anatomical, and functional outcome from 
bilateral lesions to motor cortex at P10. 
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Basic fibroblast growth factor improves physiological, anatomical, and functional 
outcome from bilateral lesions to motor cortex at postnatal day 10 
1. General Introduction 
Overview 
The specific focus of the present thesis was to examine brain plasticity at postnatal day 
10 (PI0) in response to two different types of experience: exposure to FGF-2 and/or 
bilateral lesions of the motor cortex. More specifically, the thesis examined whether the 
functional and structural outcome following bilateral injury to the motor cortex inflicted 
at P10 could be ameliorated by exogenous administration of a growth factor (FGF-2). In 
the introduction, the crucial steps involved in neocortical development, and the role of 
FGF-2 during development and following brain damage, are reviewed. Then, the specific 
objectives and hypotheses on which this thesis rests are outlined. 
Development of neocortex in the rat 
In vertebrates, the entire central nervous system (CNS) is derived from a group of 
epithelial cells contained within the neural tube of the developing embryo. The neural 
tube forms when the neural plate along the dorsal surface of the embryo rolls up and 
closes off from a strip of overlying ectoderm. The cells from this region form the pool of 
stem cells from which the entire brain and spinal cord originate. Early during 
development, most cells are undergoing active proliferation. This proliferative phase 
continues throughout embryogenesis, but is restricted to the cells from ventricular and 
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subventricular zones. As neural development continues, many of the cells exit the 
proliferative region, migrate out, and differentiate into neuron or glia (Ford-Perriss et al., 
2001). The mammalian CNS develops through a sequence of complex cellular processes. 
The classical account of brain development was predominantly based on the use of 
titriated thymidine to label different phases of development - neurogenesis, migration, 
synaptogenesis. More recent work looks at CNS development within the framework of 
an embryology program defined through distinct molecular expression patterns (Flatten, 
1999). Within this framework, genes that are expressed during neural induction initiate 
the program of CNS development (Harland, 1997), the first step of which involves the 
establishment of anterior/posterior axis (Rubenstein, 1998). As different transcription 
factors express themselves within different regions of the emerging CNS, different pools 
of cells acquire dorsal or ventral identity on the axis. The cells' position on the axis 
dictates whether they will become cortical or subcortical. This gene expression program 
is in progress at early embryonic periods (E8.5- El3) that coincide with a period of 
neurogenesis. Then, different cues guide the migration of neurons along radial glial cells 
to their appropriate targets. Early in development, proliferating precursor cells in the 
neuroepithelium move from one rhombomere to the other (Jessell & Lumsden, 1997), but 
eventually, they settle into a specific position, and from there, many will begin radial 
migration along glial fibers. 
Radial glial migration 
Much evidence supports the theory that radial glia provide a scaffold for directed 
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migration in the brain (Rakic 1971, 1972, 1978; Hatten, 1983; Anton et al., 1996). Early 
in development, glial cells extend processes and create the primary route for migration. 
As the first populations of neurons migrate away from the ventricular zone, a region of 
axons is created and forms the intermediate zone (IG). Around E8-E9.5, the 
dorsal/ventral axis is established by the expression of bone morphogenic proteins (BMPs) 
and Sonic Hedgehog (Shh). Migration occurs after regionalization specifies a plan for 
cell fate specification. This plan orchestrates the blue print particular to different brain 
regions. Neurons eventually stop their migration, thanks to cues provided by target 
axons, as well as de-adhesion signals. The majority, but not all, of cells migrate through 
the radial glial scaffold. A subpopulation of cells migrate tangentially (O'Rourke et al., 
1997). 
Within the developing neocortex, another important area develops above the ventricular 
zone- the subventricular zone (SVZ). The SVZ, first described by Altman (1969) 
maintains a proliferative pool of stem cells throughout life (Garcia et al., 1998). The 
SVZ is one of three areas that remain proliferative into adulthood, the other two being the 
olfactory bulbs and the hippocampus (Seaberg & van der Kooy, 2002). 
Differential developmental plasticity- P3* P10* P90... 
Rats that receive neocortical injury display a broad range of behavioral and anatomical 
outcomes that vary depending on the age at the time of lesion, whether the injury is 
unilateral or bilateral, the site and extent of the damage inflicted, and the precise 
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behavioral tests employed (e.g., Kolb, 1995). For example, bilateral injury of the medial 
prefrontal cortex (mPFC) inflicted around postnatal day 10 (P10) leads to remarkable 
functional and anatomical recovery including a filling of the lesion cavity with newly 
generated neurons and glia, and increased dendritic arborization in pyramidal cells 
throughout the remaining neocortex (e.g., Kolb, 1995; Kolb et al., 1998). In contrast, 
injury inflicted earlier (postnatal days 1-6) in development or in adulthood leads to severe 
behavioral deficits and no filling of the lesion cavity or dendritic hypertrophy. These 
results a priori suggest that there may be something particular about P10 that allows 
recovery of function and its underlying anatomical changes. Curiously, the filling of the 
lesion cavity is not observed after P10 lesions in other cortical areas, including both 
anterior and posterior regions (e.g., Gonzalez, Whishaw & Kolb, 2003). Interestingly, 
despite the fact that P10 lesions in other cortical regions do not show a spontaneous 
filling of the lesion cavity, those rats that receive lesions at P10 recover better than their 
PI or P90 counterparts, but in no case do they show recovery that is as extensive as in 
animals with mPFC lesions that show generation of new tissue. It thus appears that the 
recovery seen after mPFC lesions at P10 may be related both to synaptic changes in the 
remaining brain as well as to the generation of new neurons and glia. Different 'things' 
are happening throughout development. It should not come as a surprise, therefore, that 
the brain reacts differently to injury depending on the time at which it is affected. We 
are, in essence, damaging a 'different brain' when inflicting injury at various time-points 
throughout development. For example, at P3 the rat brain is still undergoing 
neurogenesis. At P10, however, neurogenesis is complete (with the exception of two 
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focused areas), and the brain is undergoing the peak of synapse formation. Knowing this, 
we can capitalize on the fact that the brain is different throughout development. Doing so 
provides us with the opportunity not only to understand the developing brain better, but 
understand the different principles that function to hinder or facilitate recovery of 
structure and function in response to injury. Once we understand these principles better, 
we may be in a position to apply the derived mechanisms to different situations (i.e., 
different regions or developmental timepoints) to enhance recovery of function. 
Different signaling molecules play important roles during brain development, and 
contribute to the differential recovery seen at different developmental ages. Members of 
the FGF family, for example, have multiple critical functions during the formation of the 
CNS as well as following injury, and several members are differentially regulated and 
expressed throughout development. Of particular interest to the present thesis, is basic 
fibroblast growth factor (FGF-2). 
Basic fibroblast growth factor (FGF-2) 
FGF-2 was discovered in 1984 (Thomas et al., 1984). Along with FGF-1, it was found to 
be a potent modulator of proliferation in the developing CNS. FGF-2 is expressed early 
in development, and persists into adulthood. It is also expressed in a wider range of 
tissue than FGF-1 (Vaccarino et a l , 1999). Whereas FGF-2 is expressed in both neuronal 
and non-neuronal cells, FGF-1 is predominantly neuronal (Eckenstein, 1994). FGF-2 
exists as 4 different molecular forms, including 3 high molecular weight (HMW; 21.5, 
6 
22, and 24 kD), and one 18 kD forms. The HMW FGF-2 are usually expressed in the 
nucleus, whereas the 18 kD form is cytoplasmic. Extracellularly, FGF-2 exerts its effects 
by interacting with specific cell surface receptors. Four major receptors have been 
identified for FGF-2: FGFR1, FGFR2, FGFR3, and FGFR4. 
The 18 kD FGF-2 is found in the cytoplasm, but it is also released from the cell. This 
process involves 2 components: (1) release of 18 kD FGF-2 from the inside of the 
extracellular compartment; and, (2) release of cell surface, or matrix-bound FGF-2 into 
the extracellular environment. 
FGF-2 and development 
Several FGFRs and their ligands (including FGF-2) are expressed in the developing CNS. 
FGF-2 is a potent proliferative factor for telencephalic progenitor cells in vitro and in 
vivo (Vaccarino et al., 1999). For example, Murphy, Drago and Bartlett (1990) found 
that in E10 mice, 50% of neuroepithelial cells divide in the presence of FGF-2. In the 
absence of FGF-2, those cells die in culture within 6 days. It appears that FGF-2 might 
stimulate proliferation of precursor cells for the entire CNS- Ray and Gage (1994) found 
that neural precursor cells from embryonic spinal cord also proliferate in the presence of 
FGF-2. FGF-2 null mutants are viable, but display cerebral cortex defects. They show, 
for example, a reduction in parvalbumin positive neurons in cortical layers and an overall 
reduction in neurons and glia. This is most pronounced in frontal and sensory areas. 
Neuronal deficiencies are also found in the spinal cord of these mice. Cell density in 
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many other areas, however, appears normal. The knock-out mice show a reduced density 
of neurons in sensory and motor areas of the cortex, but not in the striatum or cerebellum 
(Vaccarino et al., 1999), and Raballo et al. (2000) have suggested that the major effects 
of FGF-2 loss are localized to the dorsal regions of the brain (i.e., cortex). Raballo et al. 
(2000) have shown that FGF-2 is necessary for cell proliferation and neurogenesis in the 
developing neocortex by demonstrating that: (1) FGF-2 is expressed in the 
pseudostratified ventricular epithelium (PVE) in a dorsoventral gradient; (2) FGF-2 and 
its receptors are downregulated during the later stages of neurogenesis; and, (3) in FGF-2 
knock-outs, the dorsal PVE shows a 50% decrease in founder cells as well as a reduced 
expansion of the progenitor pool throughout neurogenesis such that by the end of 
neurogenesis, cortical number is reduced, and the mice lack large neurons in the deep 
layers of the cortex, but the number of neurons in the basal ganglia remains unaffected. 
Bromodeoxyuridine labeling in FGF-2 knock-out mice has demonstrated that FGF-2 
increased the population of dividing and proliferating cells cells without affecting the 
length of the cell cycle (Vaccarino et al., 1999; Raballo et al., 2000). The degree of 
apoptosis within the VZ was not changed in FGF-2 knock-outs, suggesting that FGF-2 
does not act as a survival molecule in vivo (Raballo et al., 2000). FGF-2 and its receptors 
are highly expressed during early stages of embryogenesis (El 0-12 in rodents), and the 
deepest layers of the cortex are dividing and differentiating. This result correlates with 
the finding that the neurons that are lost in FGF-2-deficient mice are the large neurons in 
deep cortical layers (Raballo et al., 2000). Raballo et al. (2000) conclude that FGF-2 is 
likely necessary for a specific class of cortical neurons arising from the PVE. FGF-2 has 
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a spatially- and temporally-defined role, which is to initiate or maintain cell division of 
neural precursors in the dorsal regions of the telencephalon during the early stages of 
embryogenesis. Vaccarino et al (1999) have shown that cortical volume and neuron 
number were increased by FGF-2 microinjection at E15.5. Similar injections at E20.5 
resulted in an increase in glia (but not neurons). In their study, they counted the number 
of neurons and glial cells at P21. It appears that FGF-2 might serve to amplify 'what is 
already there'. A different study has shown that the regulation of progenitor maturation 
within the developing cerebral cortex by Wnt depends on Shh or FGF-2. As previously 
alluded to, the cerebral cortex develops from two germinal layers- the ventricular zone 
(VZ), a pseudostratified epithelium that lines the lateral ventricles, and the subventricular 
zone (SVZ), which begins to develop at approximately El3 in mice. Viti et al. (2000) 
found that BMPs and FGF-2 act antagonistically to regulate the development of a subset 
of SVZ progenitors that normally express a high level of EGF receptors and divide in 
response to EGF. In addition, Wnt 7a, Wnt 7b, and Shh together, or FGF-2 alone, 
promote progenitor maturation in culture. Wnt 7a and Wnt 7b also stimulate the 
proliferation of neurogenic progenitors and increase the number of cells that can generate 
neurospheres. Viti et al. (2000) investigated whether Wnts, FGF-2 and Shh act 
independently or in a common pathway, by inhibiting each factor individually in cortical 
explant, and found that all three normally contribute to progenitor maturation. 
Furthermore, Wnt 7a depends on FGF-2 or Shh to promote maturation (but not 
proliferation). Maturation induced by bone morphogenic proteins (BMPs) is also 
dependent on FGF-2. FGF-2, however, promotes maturation by a Shh-independent 
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mechanism. In addition to its role in development, FGF-2 has also been shown to play a 
role following injury. 
FGF-2 and injury 
Reilly and Kumari (1996) have shown that FGFRs are expressed by astrocytes, and that 
they (FGFRs) are upregulated in response to injury. They have also shown that FGF-2 
itself is also expressed in the nucleus of astrocytes that stain for FGFRs. The authors also 
demonstrate that there is a time course for astrocyte expression of FGFRs that precedes 
and parallels astrocyte hypertrophy in response to injury. Reilly and Kumari's study 
(1996) suggests that an autocrine action of endogenous FGF-2, acting directly on FGFR-
expressing astrocytes contributes to astrogliosis in response to injury. Other studies 
report a similar mechanism. Baird and Walicke (1989) as well as Logan (1990) have 
independently shown that FGF-2 acting through FGFR1 plays a role in the regulation of 
CNS injury processes, including transformation of reactive astrocytes, angiogenesis, scar 
formation, and promotion of neurotrophic factor release. FGF-2 is found on astrocytes 
(Reilly & Kumari, 1996) as well as neurons (Gonzalez et al., 1995). Evidence suggests 
that FGF-2 may translocate to the nucleus after binding to FGFR1 in the nuclear 
periphery (Stachowiak, 1997). Providing further evidence to that effect, Clarke et al. 
(2001) have demonstrated upregulation and trafficking of FGF-2 and FGFR1 to the 
nucleus of reactive astrocytes in vivo. Using a different model of injury- hypoxia- Ganat 
et al. (2002) have shown that levels of FGF-1 and FGF-2 increase following 2 weeks of 
hypoxia. According to Ganat et al.'s results, in undamaged brains, FGF-2 is expressed in 
10 
the nucleus of GFAP-expressing astrocytes. After hypoxia, however, FGF-2-containing 
cells seem to revert to a more immature state as now they express vimentin, but no longer 
express GFAP. Hypoxia evidently promotes the appearance of radial glia throughout the 
subventricular and subependymal zones. A subset of these cells express FGFR1 and are 
in close proximity with FGF-2 positive cells in the SVZ. It is thought that FGFR 
signaling in radial glia might act to regulate cell genesis following injury (Ganat et al., 
2002). 
Why study bilateral motor cortex lesions inflicted at P10? 
The roles that FGF-2 play both throughout development as well as following injury 
suggest that it may prove to be different depending on the age at injury, and the area 
damaged. In the present thesis, we have chosen to focus on one specific timepoint, P10, 
and one particular area, motor cortex. We chose to study animals with bilateral P10 
motor cortex lesions for two reasons. First, although rats with P10 motor cortex lesions 
show a better outcome than animals with day 1 or adult lesions, they are still profoundly 
impaired at skilled motor tasks (e.g., Kolb, Cioe & Whishaw, 2000). Second, we made 
bilateral rather than unilateral lesions because we wished to ensure that any enhanced 
motor function was not due to changes in the normal hemisphere of unilaterally-injured 
animals. Importantly, both the damage itself, but also the changes that occurred as a 
result of the damage, will have an effect on behavioral outcome. For that reason, we 
believe that using a combination of complimentary techniques is most effective in 
assessing outcome following injury. 
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Objectives and hypotheses 
The main objective of the present thesis was to evaluate whether exogenous 
administration of FGF-2 could improve functional and structural outcome following P10 
bilateral injury to the motor cortex. Based on prior work conducted in the Kolb lab (Gibb 
et al., 2004) we hypothesized that it would. If so, we were interested in isolating what the 
mechanism(s) underlying the functional and structural recovery might be. We set out to 
examine theses questions with four complimentary studies that each assessed the role of 
FGF-2 in mediating recovery from bilateral motor cortex injury inflicted at P10. In order 
to best describe the changes induced as a result of bilateral lesion to the motor cortex and 
exogenous administration of FGF-2, data were collected from multiple levels of analysis 
(behavior, cortical mapping, EEG activity, multi-unit activity, EMG activity, dendritic 
morphology, electron microscopy, neuroanatomical tracing, and immunohistochemistry). 
The logic and sequence of experiments were as follows: Study 1 aimed to thoroughly 
describe the spatial and phenotypic distribution of FGF-2 throughout development. The 
goal was to evaluate whether a differential temporal and spatial expression of FGF-2 
throughout development might be partially responsible for the differential recovery 
observed from cortical lesions inflicted at different time points after birth. 
We then aimed to examine the effects of exogenously applying FGF-2 on the functional 
recovery following a bilateral motor cortex lesion inflicted at P10. We show that FGF-2 
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is associated with functional recovery, as well as a filling of the lesion cavity with some 
tissue (Study 2). The goal of Study 2 was to assess the functionality of the tissue filling 
the cavity, tissue surrounding it, and tissue from the motor cortex (in control rats) using 
intracortical microstimulation to evoke movement, and to derive and analyze the caudal 
forelimb area map in each rat. Following mapping, the rats were perfused and processed 
for Golgi-Cox staining. Medium spiny neurons from the striatum were drawn and 
analyzed to evaluate whether the functional recovery observed might be, at least in part, 
due to a change in dendritic morphology in the striatum. 
In Study 3, we evaluated the electrophysiological and anatomical integrity of 
corticospinal projections in motor cortex lesioned rats that receive FGF-2. Rats received 
bilateral MCx lesions on P10. Beginning with day 11, they received subcutaneous 
injections of either vehicle or FGF-2 for 7 days. In adulthood, the physiology of 
corticospinal projections was evaluated using intracortical microstimulation and 
recording electromyographic (EMG) activity in wrist extensors. Corticospinal 
projections were also anterogradely traced using biotin dextran amine (BDA). 
Finally, in Study 4 we examined the structural and anatomical integrity of this filled 
region in 5 different experiments. In the first experiment, rats were sacrificed at P14 and 
P21 and their brains processed for Ki67 and doublecortin immunohistochemistry to 
identify migrating neuroblasts and proliferating cells. In the second experiment, the 
synaptic organization of the tissue from the filled the cavity, area Cg3, and MCx (in 
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control rats) was assessed in adulthood (P90), using light and electron microscopy 
techniques. Unbiaised stereology was used to derive a measure of synaptic density, 
neuron density, and synapses per neuron from each area. In the third experiment, EEG 
and multi-unit recordings were performed in P90 rats from MCx (in controls) and from 
the filled region (in lesion, FGF-2 treated rats). Experiment 4 aimed to examine whether 
preventing the filling of the lesion cavity with FGF-2 administration would prevent the 
functional recovery. Pregnant dams were injected with Bromodeoxyuridine (BrdU) on 
embryonic day 13 (El3). BrdU treatment at E l3 is thought to put a halt to the pool of 
stem cells from the subventricular zone that would be destined to migrate to the deep 
layers of cortex- and that might be responsible for filling the lesion cavity following 
FGF-2 injections. The progeny received bilateral P10 motor cortex (or sham) lesions, as 
well as injections of FGF-2 or saline. When they reached P45 the 4 groups of BrdU -
exposed rats, as well as groups of matched controls, were trained and assessed on the 
Whishaw tray reaching task. In Experiment 5, control rats and lesion rats that received 
FGF-2 were re-lesioned in adulthood. They received a unilateral lesion of motor cortex 
(or filled region) contralateral to their reaching forelimb. Their reaching ability and 
forelimb asymmetry were assessed before and after the re-lesioning. 
14 
Marie-H. Monfils*, Ira Driscoll, Neal R. Melvin, Bryan Kolb 
Submitted to Neuroscience, September 12, 2005. 
Chapter 2: Differential expression of FGF-2 in the developing rat brain: a potential 
mechanism underlying recovery from injury 
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Abstract 
Basic fibroblast growth factor (FGF-2) is a trophic molecule involved in a number of 
functions within the central nervous system (CNS), including a prominent role in the 
regulation of CNS responses to injury. Prior studies suggest that rats recover differently 
from injury inflicted to different regions and at different ages throughout development, 
and that FGF-2 might be underlie this phenomenon. In the present study, we describe the 
distribution of FGF-2 at PO, P2, P6, P10, P12, P14, P18, P21 and P30 in the indusium 
griseum, the external capsule, the hippocampus, the medial prefrontal cortex, the motor 
cortex, the rostral migratory stream, and the subventricular zone. Our results suggest a 
differential temporal and spatial expression of FGF-2 throughout development, which 
may explain the differential recovery observed from cortical lesions inflicted at different 
time points after birth. 
Key words: Vimentin, FGF-2, GFAP, subventricular zone, development. 
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Basic fibroblast growth factor (FGF-2) is a trophic molecule involved in a number of 
functions within the central nervous system (CNS) (Bikfalvi et al.,1997; Ford-Perriss, 
2001). Four different molecular forms of FGF-2 are found in the rat brain (18, 21, 21.5, 
and 22K). The 18K FGF-2 is predominantly cytoplasmic or excreted and stored in the 
extracellular matrix, whereas the higher molecular mass FGF-2 isoforms preferentially 
localize to nuclear and ribosomal fractions (Prats et al., 1989). FGF-2 is expressed in 
both neurons and astrocytes (Emoto et al., 1989; Endoh et al., 1994), and is known to 
stimulate astrocytic differentiation (Reilly & Kumari, 1996), induce neurogenesis 
(Wagner et al., 1999), enhance neuronal survival and outgrowth both in vivo and in vitro 
(Ramirez et al., 1989; Walicke, 1988), and to play a prominent role in the regulation of 
central nervous system injury responses (Baird and Walicke, 1989; Logan, 1990), 
including scar formation (Logan, 1990), and promotion of neurotrophic factor release. 
Recently, FGF-2 infusion was found to improve sensorimotor deficits and to reduce 
infarct size following cerebral ischemia in adult rats (Li & Stephenson, 2002). 
Furthermore, application of FGF-2 leads to anatomical, physiological, and behavioural 
recovery following motor cortex lesions inflicted at postnatal day 10 (Monfils et al., 
2005), and neutralizing antibodies to FGF-2 blocks recovery from motor cortex lesions in 
adult rats (Rowntree & Kolb, 1997). 
Prior studies suggest that rats recover differently from injury inflicted to different 
regions and at different ages throughout development (Kolb et al., 2000a; Kolb et al., 
2000b; Kolb et al., 1996). Specifically, rats show poor recovery after injury in the first 
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week of life whereas they show dramatic recovery in the second week (Kolb et al., 
2000a). One explanation for this difference in recovery is that there is a time-dependent 
expression of trophic factors such as FGF-2 in recovery (e.g., Gibb & Kolb, 2005). Yet, 
despite evidence for a plausible role of FGF-2 in recovery from early injury, little is 
known regarding its protein expression throughout the brain throughout postnatal 
development. 
We suggest that a different spatial distribution of FGF-2 at various time points 
throughout development could in part underlie the differential recovery observed 
following cortical lesions inflicted at different time points after birth. Thus, in the present 
study, we examined the distribution and phenotypic characteristics of FGF-2-expressing 
cells at P0, P2, P6, P10, PI2, PI4, PI7, P21 and P30 in the indusium griseum (IG), 
corpus callosum (CC), hippocampus (HPC), medial prefrontal cortex (mPFC), motor 
cortex (MCx), rostral migratory stream (RMS), and subventricular zone (SVZ). 
Materials and Methods 
All experiments were conducted in accordance with the guidelines set forth by the 
Canadian Council for Animal Care. Male Long-Evans hooded rats were intracardially 
perfused with phosphate buffered saline (PBS) (0.1 M, 0.9 %) followed by phosphate 
buffered paraformaldehyde (PFA) (4%) at postnatal day 0 (P0), 2, 6, PI0, PI2, PI4, PI 8, 
P21 and P30 (n=3 for each age group). Following perfusion, the brains were stored in 
phosphate buffered sucrose (30%), then microtome-sectioned coronally at 30 u,m, and 
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stored in PBS until processing. 
Three series of sections were obtained from each brain. One series was processed for 
FGF-2 immunochemistry with DAB reaction. The DAB processing steps were as 
follows. Free-floating sections were first placed in a 0.3% peroxide solution and washed 
in IX PBS, then incubated overnight in a 1:400 dilution of FGF-2 rabbit anti-FGF-2 
(Santa Cruz Biotechnologies). The next day, the sections were developed using the ABC 
method (Vector-Elite). A subportion of the brains (P6, P10, P12, P18, P21) were also 
processed for FGF-2 as well as either doublecortin, NeuN, or GFAP and vimentin to 
establish the phenotype of the cells that expressed FGF-2. Free-floating sections were 
incubated overnight in a dilution of primary antibodies (rabbit anti-FGF-2, 1:250; Mouse 
anti-NeuN, 1:500; chicken anti-vimentin, 1:1000; Mouse anti-GFAP, 1:1000). The next 
day, the sections were processed for fluorescence using secondary antibodies specific to 
the primary antibodies (Cy3 anti-rabbit, biotinylated anti-mouse and Streptavidin 488, 
Cy5 anti-chicken). 
Results 
Indusium griseum 
Cells from the indusium griseum expressed FGF-2 at P0 (see Fig, 2-1). The reactivity 
was faint, but was observed consistently in this region across all the P0 brains that were 
processed (n=3). There was no qualitative difference between P0 and P2. By P6, 
however, FGF-2 expression in the IG increased in intensity. It peaked at P21, and 
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Figure 2-1 Expression of FGF-2 in the indusium griseum, tenia tecta, and subventricuar 
lining throughout development. FGF-2 first appeared in the indusium griseum (IG) at PO. 
It increased in intensity at P6 and the level of expression was maintained thereafter. In 
the tenia tecta (tt), FGF-2 was first expressed at P6 and peaked at P21. In the 
subventricular lining (svz), FGF-2 was first expressed at P10, and was consistently 
expressed thereafter. 
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seemed to return to a slightly lower intensity by P30. As can be seen in Fig. 2-2, the IG 
cells that expressed FGF-2 were double-labelled with NeuN and thus were neurons. 
Septum 
Cells from the septum expressed FGF-2 at P6 (see Fig. 2-1). FGF-2 expression was 
qualitatively consistent across later ages, and peaked at P21 just like in the IG. As can be 
observed in Fig. 2-2, the septal cells that expressed FGF-2 were neurons. 
Hippocampus 
In the hippocampus (HPC), FGF-2 was expressed at P0 in the anterior portion of CA1 
(see Fig. 2-3). In caudal sections of the HPC, it was expressed in the most lateral and 
medial portions of CA1 (see Fig. 2-5). Beginning with P10, an interesting pattern of 
FGF-2 distribution developed in the anterior portion of the HPC. Specifically, as shown 
in Fig. 2-3, from P10 and older there appears to be a gap between two robust bands of 
FGF-2 expression. The gap seems to be located in a portion of CA1, and the 2 areas 
expressing FGF-2 appear to comprise the medial and lateral edge of CA1, as well as 
CA2. Interestingly, there are still some FGF-2 positive cells within the gap described 
here, but the cells are far less dense in that region and they display a phenotype that is 
clearly distinct from what is seen in the FGF-2-dense regions. Fig. 2-4 shows that, in 
those FGF-2-dense regions, FGF-2 is expressed in neurons. 
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Figure 2- 2. Co-localization of FGF2 and NeuN in the indusium griseum and tenia tecta. 
In a, co-localization of NeuN (green) and FGF-2 (red) in the indusium griseum and tenia 
tecta at 50x magnification. In b and c, higher magnification (200x) picture showing that 
FGF-2 and NeuN are both expressed in cell nuclei from the indusium griseum (b) and 
tenia tecta (c). The example shown was obtained from a P10 rat. However, this 
expression pattern was consistent across all ages examined (P6, P10, PI2, PI4, PI 8, 
P30). 
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Figure 2- 3 FGF-2 expression in rostral hippocampus throughout development. From PO 
to P10, FGF-2 was only expressed in the most medial region of the hippocampus. 
Beginning with day 10, and persisting thereafter, an interesting expression pattern 
developed: there appears to be a gap between two robust bands of densely expressed 
FGF-2 positive cells. The gap seems to be located in a portion of CA1, and the 2 areas 
expressing FGF-2 appear to comprise the medial and lateral edge of CA1, as well as 
CA2. Interestingly, there are still some FGF-2 positive cells within the gap described 
here, but the cells are far less dense in that region and they display a phenotype that is 
clearly distinct from what is seen in the FGF-2-dense regions. 
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Figure 2- 4 Co-expression of FGF-2 and NeuN in distinct regions of the rostral 
hippocampus. As shown in a, FGF-2 and NeuN were co-expressed in CA2, and in the 
medial portion of CA1. In b, higher magnification (200x) showing that the nuclei of cells 
nuclei in CA2 co-expressed FGF-2 and NeuN. 
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Figure 2- 5 Expression of FGF-2 in the caudal hippocampus throughout development. 
In caudal sections of the hippocampus, FGF-2 was expressed in dense clusters in the 
most medial portions of CA1 from PO onward. From P10 on, FGF-2 was expressed 
ubiquitously throughout the hippocampus, yet, densely packed clusters of FGF-2 positive 
cells were still prominent in the most medial and lateral portions of CA1. 
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External capsule, motor cortex and medial prefrontal cortex 
FGF-2 was differentially expressed within different cortical regions. Within the medial 
prefrontal cortex (mPFC), FGF-2 first appeared at P14 (data not shown), was consistently 
expressed thereafter, and peaked at P21, similarly to the IG and septum. In motor cortex 
(MCx), FGF-2 was first expressed at P10, and was consistently expressed thereafter (see 
Fig. 2-6). The expression of FGF-2 in the external capsule paralleled that seen in the 
MCx. Thus, as shown in Fig. 2-6, FGF-2 in the CC was first expressed at P10, and was 
consistently expressed thereafter. In the mPFC, the MCx, as well as the CC, FGF-2 was 
expressed in mature astrocytes (data not shown). 
Rostral migratory stream and subventricular zone 
FGF-2 was not expressed in either the rostral migratory stream (RMS) or the ventricular 
lining until P10 (see Fig. 2-6). FGF-2 expression peaked at P14, and remained at that 
level across all subsequent ages. As can be seen in Fig. 2-7, the cells that expressed FGF-
2 in the ventricles were not neurons. They did not express NeuN, and they can also be 
recognized as distinct from neurons based on their smaller cell bodies. Interestingly, a 
number of SVZ FGF-2 positive cells were colocalized with vimentin only between P10 
and P14 (See figure 2-8). By PI 8, however, the majority of FGF-2 positive cells 
expressed both vimentin and GFAP (See figure 2-9). By P30, the vimentin positive cells 
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in the SVZ no longer expressed FGF-2. Furthermore, FGF-2 expression was 
predominantly restricted to the nucleus across all ages, with the exception of P10-P14, at 
which point it was expressed both in the nucleus (in a portion of cells), and in the 
cytoplasm (in other cells). 
Discussion 
The results of our study suggest that there is a differential distribution of FGF-2 
throughout development that is region-specific and age-dependent. To our knowledge, 
this is the first study to thoroughly describe the developmental distribution and 
phenotypic characterization of FGF-2 protein expression within the rat brain. Other 
studies (e.g., Gomez Pinilla et al., 1995) have reported protein expression of FGF-2 in the 
developing brain with an emphasis on certain structures, but here we attempted to 
globally describe FGF-2 expression. Our results suggest that the differential temporal 
and spatial expression of FGF-2 throughout development may play a role in the 
differential recovery observed from cortical lesions inflicted at different time points after 
birth. We discuss this possibility within the framework of past research conducted on 
early cortical lesions in the rat. 
First, in a number of regions described here, FGF-2 expression peaks at P21. This 
finding is in accordance with a previous study, which reported that FGF-2 messenger 
ribonucleic acid (mRNA) peaked at P21 (Riva & Mocchetti, 1991). Second, FGF-2 is 
expressed in neurons, as well as glial 
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Figure 2- 6. Distribution of FGF-2 in the subventricular zone, motor cortex, and external 
capsule. FGF-2 was first expressed in the subventricular zone, the motor cortex and the 
external capsule at P10. Higher magnification (200x) shows an originally faint expressed 
of FGF-2 in the motor cortex at P10. FGF-2 expression in the motor cortex was robustly 
expressed from P21 onward. 
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Figure 2- 7. Distribution of FGF-2 in the lateral portion of the subventricular zone 
(SVZ). FGF-2 was first expressed in the subventricular zone at P10. Higher 
magnification (200x) shows an originally faint expressed of FGF-2 in the SVZ at P10. It 
peaked at PI4, and was robustly expressed from then onward. 
Figure 2- 8. Glial phenotype of FGF-2 expressing cells in the subventricular zone and 
rostral migratory stream at postnatal day 12. At PI2, FGF-2 positive cells were found at 
the lateral edge of the subventricular wall. Higher magnification (b, c, and d) shows that 
FGF-2 positive cells co-expressed the immature astrocytic marker vimentin (shown in 
green). A portion of FGF-2 positive cells were co-localized with GFAP (b). In the 
rostral migratory stream (e) both FGF-2 and vimentin positive cells were expressed, but 
were not co-localized. 
Figure 2- 9. Glial phenotype of FGF-2 expressing cells in the subventricular zone and 
rostral migratory stream at postnatal day 30. At P30, FGF-2 positive cells were found at 
the lateral edge of the subventricular wall. Higher magnification (b, c, and d) shows that 
most FGF-2 positive cells did not co-expressed the immature astrocytic marker vimentin 
(shown in green). Vimentin positive but not FGF-2 positive cells were expressed in the 
In the rostral migratory stream (e). 
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cells. The spatial distribution of FGF-2 expression by the two different cell phenotypes 
appears to be consistent throughout development. This finding confirms the conclusions 
of prior studies that reported that FGF-2 was expressed by both neurons and glial cells in 
different brain regions (Gomez-Pinilla et al., 1994). Our study extends these findings to 
distinct regions throughout the developing brain and suggests that the phenotypic 
distribution within structures remains constant throughout postnatal development. Third, 
FGF-2 expression appears to be differentially expressed across subregions of the 
hippocampus. This finding was previously reported to occur in the adult (Kuzis et al., 
1995), and developing rat brain (Gomez-Pinilla et al., 1994; Kuzis et al., 1995). 
Although our results differ slightly from those reported by Gomez-Pinilla et al. (1994), 
there are methodological differences in the protocols and the precise antibodies that may 
account for the differences. Their FGF-2 antibody recognized the molecular 
conformation related to the biological activity of FGF-2. Because the brains were 
perfused in PFA (which cross links proteins) prior to immunoprocessing, it is possible 
that the biological activity of FGF-2 was altered and affected its expression, and thus 
could account for the discrepancy between our and their findings. The significance of the 
differential distribution of FGF-2 throughout the hippocampus is currently unknown, but 
suggests a differential role of FGF-2 for distinct subpopulations within this region. 
Interestingly, however, all the brain regions in which FGF-2 shows a neuronal expression 
are strongly interconnected (i.e., the IG, HPC and septal area) and originate from the 
same embryonic subregion. 
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The results we observed in the subventricular zone are particularly interesting 
because they show that (1) there are no FGF-2 expressing cells in this region until P10, 
and (2) the co-localization of FGF-2 expressing cells with glial cells is differentially 
regulated across development. Thus, between P10 and PI 8, a portion of cells expressed 
FGF-2 and vimentin only, whereas others co-expressed FGF-2, vimentin, and GFAP. At 
P30, the vimentin positive/GFAP negative cell population no longer expressed FGF-2. 
The differential expression of FGF-2-reactive glial cells in the SVZ may be 
important for understanding the recovery observed after perinatal cortical lesions. Rats 
with lesions anywhere in the cortical mantle from postnatal day 1-5 show a dismal 
functional outcome whereas similar lesions from day 7-15 show a much better outcome, 
with the best outcome roughly around day 10 (e.g., Kolb, 1995). The enhanced 
production of glial cells in the second week could result in the increased production of 
FGF-2 and we thus have proposed that FGF-2 may play an important role in mediating 
the observed recovery (Gibb & Kolb, 2005). Indeed, we have recently shown that 
exogenous application of FGF-2 after medial frontal or posterior parietal lesions on day 3 
(Comeau et al., 2005) or motor cortex lesions on day 10 (Monfils et al., 2005) facilitates 
recovery. We have also shown that postinjury tactile stimulation enhances functional 
recovery from day 3 lesions to medial frontal cortex, motor cortex, or posterior parietal 
cortex (e.g., Gibb & Kolb, 2005) and that this is correlated with an enhanced expression 
of FGF-2 and FGF-2 receptors in both skin and brain. It thus seems reasonable to 
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propose that the good endogenous recovery from injury around postnatal day 10 is related 
to the expression of FGF-2 by the glial cells that begin to appear after the injury. 
The fact that there are no FGF-2 positive cells in the SVZ prior to P10 (which 
coincides with the time at which the most potential for recovery is observed) provides 
support for the idea that it might play a role in recovery. Subventricular zone astrocytes 
have received much attention in recent years (for a review, see Doetsch et al., 2003a; 
Doetsch et al., 2003b). They have been shown to act as stem cells in vitro and have been 
characterized as the primary in vivo precursors for new neurons in the adult brain 
(Doetsch et a l , 1999). Doetsch et al.'s work (Doetsch et al., 1999, 2003a, 2003b) offers 
that the adult SVZ is populated by migrating neuroblasts (type A cells), precursor cells 
(type C cells), SVZ astrocytes (type B cells) and ependymal cells, and that SVZ 
astrocytes are pluripotent. Effectively, after elimination of type A and C cells, the SVZ 
repopulates and a few days later type A, B and C cells can be found in the SVZ. 
The results of the present study, in light of prior work reported from our 
laboratory, does not preclude the possibility that at least a portion of FGF-2 expressing 
cells within the SVZ might be pluripotent (between PI0 and PI8) (Kolb et a l , 1996; 
Monfils et al., 2005). They are not A cells (as evidence by the fact that they were not 
labeled with doublecortin), and they express some mature and immature astrocytic 
markers (vimentin and/or GFAP). Interestingly, Doetsch et al.'s experiment has shown 
that after elimination of type A and C cells with Ara-C treatment, the type B cells show 
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staining for vimentin, which is indicative of immature astrocytes (1999). The fact that we 
see a different expression of FGF-2 in seemingly different types of SVZ astrocytes 
(vimentin positive/GFAP negative, vimentin positive/GFAP positive, vimentin 
negative/GFAP positive) throughout different postnatal days may provide support for a 
role of FGF-2 in the differential recovery observed across those days. Our study did not 
directly test this possibility. 
Recently, Zheng et al. (2004) showed that in the absence of FGF-2 gene product, 
the dividing progenitor population of the SVZ is reduced by 50%. Furthermore, there is a 
precedent in the literature suggesting that vimentin positive FGF-2 cells might show 
pluripotential. According to Ganat et al. (2002), FGF-2-containing astrocytes within the 
normal adult HPC and SVZ are non-dividing. Ganat et al. (2002) have shown, however, 
that under chronic hypoxic conditions, the majority of FGF-2 containing cells do not 
show any detectable levels of GFAP staining (but are vimentin positive) suggesting that 
hypoxia might induce those cells to revert to an immature state. In the adult brain, FGF-2 
has been shown to play a role in the response of astrocytes to injury (Reilly & Kumari, 
1996). FGF-2 expression is enhanced following injury (Clarke et a l , 2001; Ganat et al., 
2002), exogenous FGF-2 injection post injury increases astrocytic hypertrophy, and the 
expression FGF receptors 1 and 2 (FGFR1 and FGFR2) is also upregulated in response to 
cortical ischemia (Reilly & Kumari, 1996). We therefore propose that the mechanisms 
leading to astrocytic hypertrophy and FGF-2 upregulation in adulthood might recapitulate 
the permissive environment observed around P10 in the rat. In line with this idea, we 
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would predict that (1) an injury inflicted prior to P10 would not lead to recovery and 
would not induce astrocytic hypertrophy nor FGF-2 upregulation; and (2) that certain 
types of injury, provided they lead to an upregulation of FGF-2, might be beneficial to 
recovery following a second insult. There is evidence supporting both of these 
predictions. Prior to P10, hypoxia fails to induce an upregulation of FGF-2 (Ganat et al., 
2002). Furthermore, cortical lesions inflicted between PI and P5 lead to a dismal 
recovery (Kolb, 1995). Additionally, Matsushima et al. (1998) found that ischemic 
preconditioning, which is known to be neuroprotective during a subsequent ischemic 
incident, induced an increase in FGF-2 levels. 
There is a well-documented effect of exogenously applied FGF-2 on cell 
proliferation and recovery from injury, as well as a role of FGF-2 in cortical development 
(Comeau et al., 2005; Monfils et al., 2005; Reilly & Kumari, 1996; Ford-Perriss et al., 
2001). The findings presented here suggest that the differential distribution of FGF-2 
during development may account for the differential recovery observed following lesions 
inflicted at different time points. Nevertheless, the question remains as to what 
mechanism(s) might be at play to initiate such processes. Recent work (Olsnes et al., 
2003) suggests that translocation of FGFR1 to the nucleus by FGF-2 stimulation is 
induced by the 18 K molecular form. Endogenous FGF-2 can thus act on FGFR-
expressing astrocytes to modulate their response to injury. It is conceivable that, under 
permissive conditions, this mechanism might translate into a mobilization of cells to the 
site of injury, and that in turn these cells promote recovery. Evidence suggests that 
36 
subpopulations of SVZ astrocytes (namely, the ones expressing vimentin and FGF-2) 
might operate through such a mechanism. A previous study has shown that the different 
isoforms of FGF-2 may serve to differentially modulate proliferation and migration 
(Bikfalvi et al., 1997). Namely, the high molecular forms, located predominantly in the 
nucleus, control proliferation through a receptor-independent mechanism, whereas the 
low molecular form (18 K), which is found in the cytoplasm, would stimulate migration 
by autocrine receptor activation (Bikfalvi et al., 1997). 
Many studies suggest a role of FGF-2 and its receptors in brain development as 
well as in recovery from injury (e.g., Reilly & Kumari, 1996). The present results show 
that there is a differential distribution if FGF-2 expression throughout development that 
varies as a function of the brain region under investigation. We propose that this serve to 
explain the differential recovery observed following postnatal neocortical lesions 
inflicted at different time points after birth (Kolb et al., 2000a; Kolb et a l , 2000b; Kolb et 
al., 1996). Future studies will be geared towards harnessing these principles to facilitate 
recovery from injury throughout the life span, as well as to establish whether 
administering FGF-2 exogenously might prove to be beneficial following lesions to a 
brain area that is typically associated with persistent deficits (e.g., motor cortex). 
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Chapter 3: FGF-2 stimulates functional recovery after neonatal lesions of motor 
cortex in rats 
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ABBREVIATIONS 
mPFC - medial prefrontal cortex 
P10 - postnatal day 10 
PI - postnatal day 1 
P90 - postnatal day 90 
FGF-2 - basic fibroblast growth factor 
BSA - Bovine serum Albumin 
i.p. - intraperitoneally 
CFA - Caudal forelimb area 
RFA - Rostral forelimb area 
ANOVA - Analysis of Variance 
ICMS - Intracortical microstimulation 
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Abstract 
Rats were given bilateral lesions of the motor cortex on the tenth day of life (P10), and 
then received a daily subcutaneous injection of either basic fibroblast growth factor 
(FGF-2) or vehicle for seven consecutive days. In adulthood, they were trained and 
assessed on a skilled forelimb reaching task. Although all lesion groups were impaired at 
skilled reaching, the PI0 lesion group that received FGF-2 was less impaired than the 
lesion group that received the vehicle. Furthermore, the lesion rats that received FGF-2 
showed a filling of the lesion cavity with tissue, whereas the lesioned vehicle-treated rats 
still had a prominent lesion cavity. The functionality of the tissue filling the cavity, tissue 
surrounding it, and tissue from the motor cortex (in control rats) was assessed using 
intracortical microstimulation, and showed that stimulation of some sites from the filled 
cavity could evoke movement. The rats were perfused and processed for Golgi-Cox 
staining. Medium spiny neurons from the striatum were drawn and analyzed, and the 
results suggest that P10 lesions of the motor cortex induced an increase in the length and 
complexity of these cells compared to those of no lesion rats. Our results suggest that 
FGF-2 may play an important role in recovery from early brain damage. 
Key words: caudal forelimb area, dendritic morphology, golgi-cox, ICMS, 
reorganization 
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Rats that receive neocortical injury display a broad range of behavioural and anatomical 
outcomes that vary depending on the age at the time of lesion, whether the injury is 
unilateral or bilateral, the site and extent of the damage inflicted, and the precise 
behavioral tests employed (e.g., Kolb, 1995). For example, bilateral injury of the medial 
prefrontal cortex (mPFC) inflicted around postnatal day 10 (P10) leads to remarkable 
functional and anatomical recovery including a filling of the lesion cavity with newly 
generated neurons and glia, and increased dendritic arborization in pyramidal cells 
throughout the remaining neocortex (e.g., Kolb, 1995; Kolb et al., 1998). In contrast, 
injury inflicted earlier (postnatal days 1-6) in development or in adulthood leads to severe 
behavioral deficits and no filling of the lesion cavity or dendritic hypertrophy. These 
results a priori suggest that there may be something particular about P10 that allows 
recovery of function and its underlying anatomical changes. Curiously, the filling of the 
lesion cavity is not observed after P10 lesions in other cortical areas, including both 
anterior and posterior regions (e.g., Gonzalez, Whishaw & Kolb, 2003). Interestingly, 
despite the fact that PI0 lesions in other cortical regions do not show a spontaneous 
filling of the lesion cavity, those rats that receive lesions at P10 recover better than their 
PI or P90 counterparts, but in no case do they show recovery that is as extensive as in 
animals with mPFC lesions that show generation of new tissue. It thus appears that the 
recovery seen after mPFC lesions at P10 may be related both to synaptic changes in the 
remaining brain as well as in the generation of new neurons and glia. 
The goal of the current study was to determine if exogenous stimulation of cell 
generation might further improve functional outcome after P10 lesions. We chose to 
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study animals with bilateral P10 motor cortex lesions for two reasons. First, although rats 
with P10 motor cortex lesions show a better outcome than animals with day 1 or adult 
lesions, they are still profoundly impaired at skilled motor tasks (e.g., Kolb, Cioe & 
Whishaw, 2000). Second, we made bilateral rather than unilateral lesions because we 
wished to ensure that any enhanced motor function was not due to changes in the normal 
hemisphere of unilaterally-injured animals. Furthermore, there is good evidence in 
humans that whereas unilateral injuries in infancy allow significant functional recovery, 
recovery from bilateral injuries, even when the injury in one hemisphere is limited, is 
surprisingly poor. For example, an infant with an injury to language zones in the left 
hemisphere and a small injury outside the homologous zones in the right hemisphere will 
show a dismal outcome, including permanent aphasia (e.g., Vargha-Khadem, Watters, & 
O'Gorman, 1985). It is thus of clinical interest to see if there might be a treatment that 
can be effective in stimulating recovery from bilateral injuries in the infant brain. 
Basic fibroblast growth factor (FGF-2) was recently proposed to account for the 
functional and anatomical recovery seen following P10 damage to the mPFC (Gibb & 
Kolb, 2005). FGF-2 is also known to induce neurogenesis (Wagner et al., 1999), enhance 
neuronal survival and outgrowth both in vivo and in vitro (Ramirez et al., 1989; Walicke, 
1988), and to play a prominent role in the regulation of central nervous system injury 
responses (Baird and Walicke, 1989; Logan, 1990); including scar formation (Logan, 
1990), and promotion of neurotrophic factors. Recently, FGF-2 was found to improve 
sensorimotor deficits and to reduce infarct size following cerebral ischemia in adult rats 
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(Li & Stephenson, 2002), and neutralizing antibodies to FGF-2 blocks recovery from 
motor cortex lesions (Rowntree & Kolb, 1997). 
The present study sought to investigate whether peripheral administration of FGF-
2 could ameliorate the functional and anatomical outcome following P10 bilateral injury 
to the motor cortex. Functional outcome was evaluated by testing the rats' performance 
on a skilled reaching task, as well as by assessing the integrity of motor cortex by using 
intracortical microstimulation to evoke movements (at PI00). Furthermore, because prior 
work reported some changes to occur in the dorsolateral striatum in response to adult 
motor cortical injury (Gonzalez & Kolb, 2003), we also measured the effects of motor 
cortex lesions and FGF-2 administration on dendritic morphology in this structure. 
Experimental procedures 
Subjects 
The present study used 20 male rats, derived from the Charles River Long-Evans hooded 
strain, which were divided into groups that received either bilateral motor cortex lesions 
(N=10) or sham operations (N=10) on postnatal day 10. The animals were group-housed, 
and then placed with same sex littermates in clear plastic cages in a colony room 
maintained on a 12h on/12h off light cycle. All experimentation was conducted during 
the light phase. Rats were maintained on Lab Diet no. 5001 (PMI feeds Inc., St-Louis, 
MO) and water ad libitum, except during the Whishaw tray reaching task, and were 
handled and cared for according to the Canadian Council for Animal Care guidelines. 
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Materials 
FGF-2 injections 
Basic fibroblast growth factor (FGF-2) was diluted in Bovine serum Albumin (BSA) (1 
u,g/ml), and administered at 0.1 ml/lOg of body weight (for a final concentration of 10 
ng/g). This concentration was determined based on the work of Wagner et al. (1999), 
which had shown this concentration to be sufficient to enhance neurogenesis in P7-P28 
rats. BSA was prepared into 0.1 M PO4 as a concentration of 1 mg/ml. 
Treatment groups 
The lesion and sham-operated rats were divided into groups that received 7 daily sessions 
of either FGF-2 (10) or BSA (10) administered subcutaneously. In a previous study 
conducted in our lab, this injection protocol was found to be effective in inducing partial 
behavioral recovery following medial prefrontal cortex aspiration lesions at P3 (Comeau, 
Hastings & Kolb, 2005). Following injections, the rats were allowed to age until P100, at 
which time they were trained on the Whishaw tray reaching task for 14 days. Then, the 
hemisphere contralateral to their preferred forelimb was mapped using intracortical 
microstimulation, and the rats were intracardially perfused and their brains processed for 
Golgi-Cox staining. 
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Lesion procedure 
The neonatal rats were anesthetized by cooling in a Thermatron cooling chamber until 
rectal temperature was in the range of 18-20°C. The bone over the motor neocortex area 
was removed with iris scissors and motor decortication was achieved by aspiration using 
procedures previously described by Kolb (1987). Kolb (1987) previously showed that, 
on postnatal day 1, the frontal cortex lies more anterior relative to bregma than it does in 
adulthood, but that the relation between the bregmoidal junction and the underlying 
cortex is constant after about postnatal day 5. Thus, the lesion was performed from +2 to 
- 2 , relative to the bregmoidal junction. The scalp wound was sutured with 5-0 Vicryl 
thread as soon as the surgery was complete. The control rats were anesthetized, the skin 
incised, and then sutured with 5-0 Vicryl thread. 
Skilled Reaching task 
Forelimb use was measured with a procedure that was adapted from the method devised 
by Whishaw et al. (1991). Each animal was food deprived to 85 % free feeding level 
throughout training and testing. The rats were placed in the test cages (10X18X10 cm 
high) with floors and front constructed of 2 mm bars, 9 mm apart edge to edge. A 4 cm 
wide and 5 cm deep tray, containing chicken feed pellets, was mounted in front of each 
box. The rats were required to extend a forelimb through the gap in the bars, grasp and 
obtain the food. The tray was mounted on runners and was retracted 0.5 cm from the 
cage so that the rats could not scrape the food into the cage. If the animal attempted to 
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rake the pellet out of the tray, the pellet would inevitably fall through the gap. An 
attempt was scored only if the rat reached into the tray and touched the food. If it 
reached into the tray without touching the pellet, no attempt was scored. A successful 
reach was defined as grasping a pellet, and bringing it to the mouth. The rats were 
trained for 20 minutes per day for 14 consecutive days. Once trained, the rats received a 
10 minute reaching test during which time they were videotaped for later scoring. All 
rats showed a forelimb preference, and only the reaches performed by the preferred limb 
were scored and analyzed. 
Intracortical Microstimulation 
Two weeks following the last reach training session (to rule out immediate effects of 
training and food deprivation on the maps), intracortical microstimulation (ICMS) was 
used to generate detailed maps of the motor cortex forelimb regions (Kleim et al., 1998) 
by experimenters that were unaware of the rats' treatment condition. Rats were 
anesthetized with ketamine hydrochloride (70 mg/kg, injected intraperitoneally [i.p.]), 
and xylazine (5 mg/kg, i.p.), and ketamine (20 mg/kg, i.p.) as supplementary injections 
when needed. A craniotomy was performed over motor cortex, and the dura was 
carefully removed. The exposed cortex was then covered with warm (37.4C) silicone oil. 
A small puncture was made in the cisterna magnum to reduce cortical edema. A glass 
microelectrode (between 0.2 and 0.7 MOhms) controlled by a hydraulic microdrive was 
used to make penetrations to a depth of ~ 1550 um (corresponding to cortical layer V), 
with an interpenetration distance of 375 urn. Stimulation consisted of thirteen, 200 |^s 
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cathodal pulses delivered at 350 Hz from an electrically isolated stimulation circuit. 
Animals were maintained in a prone position, with the limb contralateral to the side being 
supported in a consistent position. At each penetration site the minimal threshold 
required to elicit a movement was recorded. Sites where no movement was detected at < 
100 u.A were recorded as unresponsive. The level of anesthesia was assessed by 
monitoring the breathing rate and by revisiting positive-response sites to check for 
changes in movement thresholds as mapping progressed. In the control rats, mapping 
was restricted to CFA and RFA, as well as the necessary boundaries defining those 
regions. In the lesioned rats, mapping was extended to include most of the hemisphere in 
order to assess whether motor cortex had simply relocated. 
Movement representation analysis 
An image analysis program (CANVAS v. 8) was used to calculate the aerial extent of the 
caudal forelimb area (CFA). In control rats, the CFA is separated from the rostral 
forelimb area (RFA) by a band of neck/whisker representations (Kleim et al., 1998) and 
was chosen for analysis because previous work demonstrated its capacity to undergo 
reorganization following behavioural manipulations (Kleim et al., 1998, Remple et al, 
2001) or stimulation (Nudo, et al., 1990; Teskey, et al., 2002; Monfils et a l , 2004). The 
RFA has proven, thus far, to be resistant to modifications. 
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Perfusion and histology 
Following mapping, the rats were intracardially perfused with 0.9% saline, and the brains 
were removed and weighed. The mapped hemisphere was then immersed in 40 ml of 
Golgi-Cox solution (Glaser and van der Loos, 1981). The solution was changed after two 
days and the brains remained immersed for an additional 14 days before being placed in a 
30% sucrose solution for 2 days, cut on a vibratome at 200 urn, and developed using a 
procedure outlined by Gibb and Kolb (1998). 
Analysis of Dendritic Branching, Length and Spine Density 
Medium spiny neurons from the dorsolateral striatum were traced using a camera lucida 
at 260x (Occular setting- lOx, camera lucida- 1.3x, and microscope objective- 20x). 
While there were possible distance distortions generated in the peripheral portions of the 
field, tissue from all animals was treated in exactly the same manner, under blind 
conditions to eliminate any systematic bias. Dendritic trees had to maintain the following 
criteria to be included in the data analysis: (1) the cells had to be well impregnated and in 
full view, unblocked by blood vessels, astrocytes, or clustering of dendrites from other 
cells; (2) the arborizations had to appear intact and visible in the plane of section. Cells 
were chosen by locating the dorsolateral striatum (Zilles, 1985) and then drawing each 
cell in the section that maintained the above criteria. Following drawing of the cells, 
each branch segment was counted and summarized by branch order according to the 
methods of Coleman and Riesen (1968). As such, dendrites were determined to be first 
order if the branch originated from the cell body increasing in order with every 
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bifurcation. Five cells were drawn for each rat. The mean of the measurements on five 
cells per rat was used for statistical analyses. 
A Sholl analysis of ring intersections was used to estimate dendritic length (Sholl, 
1956). The number of intersections of dendrites with a series of concentric spheres at 20 
um intervals from the center of the cell body was counted for each cell. Total dendritic 
length (in um) was estimated by multiplying the number of intersections by 20. Spine 
density measures were made from a segment between 10-50 um in length. The dendrite 
was traced (at 1300x: Occular setting- lOx, camera lucida- 1.3x, and microscope 
objective- lOOx) using a camera lucida drawing tube and the exact length of the dendritic 
segment was calculated by placing a thread along the drawing and then measuring the 
thread length. Spine density was expressed as the number of spines per 10 um. No 
attempt was made to correct for spines hidden beneath or above the dendritic segment, 
therefore the spine density values are likely to underestimate the actual density of the 
dendritic spines. 
Statistical Analyses 
Factorial Analyses of Variance (ANOVAs) were performed and compared the four 
experimental groups on 6 dependent measures: brain weight, skilled reaching 
performance, CFA size, as well as striatal dendritic length, dendritic morphology, and 
spine density. Significant interactions were followed-up with Fisher's least significant 
difference tests. All statistical analyses were performed using StatView5. 
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Results 
Gross anatomy 
As in our previous studies, the untreated lesion rats all showed some degree of lesion 
cavitation in adulthood. In contrast, there was filling of the lesion cavity in the lesion rats 
that received FGF-2. Figure 3-1 illustrates that although the lesion cavity of the PI 0 
FGF-2 treated rats was filled with cells, the organization was haphazard with little 
evidence of lamination. Inspection of the Golgi-stained sections revealed that in contrast 
to normal brains in which the apical dendrites of pyramidal neurons project perpendicular 
to the cortical surface, many pyramidal cells in the in-filled cavity project at other 
orientations (see Figure 3-ID). 
Brain weight 
As expected, the brains of the lesion rats weighed less than the no lesion animals. There 
was, however, an effect of FGF-2 as the FGF-2-treated lesioned rats had significantly 
heavier brains than their untreated counterparts. A factorial (2X2) Analysis of Variance 
(ANOVA) yielded a significant main effect of Lesion (F(l,15)=13.024, p=0.0026), and a 
Lesion X FGF-2 interaction, (F(l,15)= 5.28, p= 0.0363) in brain weight. Follow-up tests 
revealed that whereas the untreated lesion rat brains weighed less than controls, the FGF-
2 treated lesion rat brain weights did not differ from their control counterparts (see Figure 
3-2, p< .05), thus leading to the significant interaction. 
Figure 3 - 1 . Distribution of cells within the filled cavity of rats that received motor 
cortex aspiration lesions at postnatal day 10 and FGF-2 treatment. The cells from the 
filled cavity did not show clear laminar distribution (B and D) compared to no lesion rats 
(A). The lesion rats that did not receive FGF-2 all showed a lesion cavity in adulthood 
(C). Pictures A, B, and C were taken at a magnification of 2.5x, and D was taken at a 
magnification of lOx. 
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No Lesion Lesion 
Figure 3- 2. Effect of postnatal day 10 motor cortex lesion and/or FGF-2 administration 
on the brain weights of adult rats. There was an effect of lesion, which indicated that the 
lesion rats had lighter brains than no lesion rats. There was also a Lesion X FGF-2 
treatment interaction whereby there was no differential effect of FGF-2 treatment for the 
no lesion rats, but the FGF-2 treated lesion rats' brains were, on average, heavier than 
those of the lesion rats that did not receive FGF-2. 
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Figure 3- 3. Effect of postnatal day 10 motor cortex lesion and/or FGF-2 administration 
on the performance of adult rats in the Whishaw tray reaching task. The no lesion groups 
are shown in white, and the lesion groups shown in gray. There was an overall effect of 
lesion on the rats' success in the skilled reaching task. There was also a Lesion X FGF-2 
treatment interaction whereby the magnitude of the difference between the lesion and no 
lesion rats was reduced in the rats that received FGF-2. Importantly, the lesion rats that 
received FGF-2 outperformed the lesion-untreated rats. 
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Skilled reaching task 
There was an overall effect of lesion on the rats' success in the skilled reaching task. 
More importantly, however, Figure 3-3 shows that FGF-2 enhanced motor performance 
in the lesion rats relative to the untreated lesion rats. A 2X2 factorial AN OVA revealed a 
main effect of lesion, F(l,15)= 70.157, p< 0.0001, as well as a significant Lesion X FGF-
2 interaction, F(l,15)= 19.203, p<0.0009, on rats' reaching success. Follow-up tests 
revealed that there was a significant difference between the control and lesion rats on the 
reaching task for both the FGF-2 and the non-FGF-2 treated groups, p< .05, but the FGF-
2 rats performed significantly better (Figure 3-3). 
Mapping of the motor cortex and filled lesion cavity 
Whereas all control rats showed clear forelimb representations, none of the lesion 
untreated rats showed any forelimb representations (Figure 3-4). In contrast, some 
movements could be elicited in all of the FGF-2 treated lesion animals. There was, 
however, a lot of variability in the type of movement that could be elicited. Two 
examples of mapping variability can be found in Figure 3-5. It is clear in Figure 5C and 
5D that, in some of the FGF-2 treated lesion rats, forelimb movements could be elicited, 
whereas in others, the movements that could be elicited were limited to other types of 
movement (shown here, predominantly vibrissae sites). Such variability in the types of 
movements that could be elicited from the filled cavity may be due to lesion variability. 
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Figure 3- 4. Quantitative representation of the effect of postnatal day 10 motor cortex 
lesion and/or FGF-2 administration on the mean areal size of the caudal forelimb area in 
adult rats. The no lesion groups are shown in white, and the lesion groups shown in gray. 
No statistical tests were performed for these comparisons, because the lesion group that 
did not receive FGF-2 did not have any variability (due to a floor effect). However, it is 
obvious that there was an overall effect of lesion. Note: in all cases, electrode 
penetrations were performed around the lesion site, as well as in and around the filled 
lesion cavity to attempt to elicit movement from these regions. 
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Figure 3- 5. Qualitative mapping data of representative rats from (A) a no lesion rat, (B) 
a lesion rat that did not receive FGF-2, (C) a lesion rat that received FGF-2 from which 
forelimb movements could be elicited, and (D) a lesion rat that received FGF-2 from 
which forelimb movements were not elicited (but that showed other responsive sites-
predominantly vibrissae). Forelimb movements are shown in dark grey, and other 
movements are shown in light grey. For each animal, a black line is also shown, 
representing bregma. There was a lot of variability in the lesioned-FGF-2 treated rats. In 
all cases, however, some type of movements could be elicited from the tissue that filled 
the lesion cavity. 
Dendritic morphology of striatal medium spiny neurons 
Our analyses revealed that, overall, striatal cells from the lesion rats had longer and more 
complex dendritic branches than the no lesion animals. Those groups did not differ, 
however, in terms of spine density, and we did not find any FGF-2 effects or differential 
FGF-2 by lesion treatment interactions. ANOVAs performed to test Lesion X FGF-2 
effects on dendritic length, branch complexity, and spine density revealed a main 
effect of lesion on dendritic length and branch complexity, F(l,15)= 6.58, p =.023, and 
F(l,15)= 13.54, p= 0.0028 (see Figure 3-6). There was no effect on spine density, and 
for either comparison, there was no significant interaction (p>.05). 
Discussion 
The main findings of the current study were that administration of FGF-2, following 
bilateral motor cortex aspiration lesions at postnatal day 10, leads to: 1) a filling of the 
lesion cavity; 2) a partial recovery of function on a skilled reaching task; and, (3) partial 
physiological recovery of the filled region. Importantly, neither the cavity filling nor the 
recovery of function were observed in the untreated lesion rats. 
Our finding of enhanced functional recovery in the FGF-2 treated animals is 
significant in the larger view of the effects of neonatal cortical lesions. We have shown 
in an extensive series of studies that neonatal cortical injury virtually anywhere in the 
cerebral cortex will produce persistent deficits in skilled reaching tasks (e.g., Kolb, Cioe, 
& Whishaw, 2002; Kolb et a l , 2000), even if the lesions are produced at the optimal time 
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for recovery, which is around 10 days of age (Kolb, 1995). In contrast, lesions to most 
cortical regions around 10 days of age allow significant recovery on cognitive tasks. 
Thus, it appears that motor deficits are more persistent, and as such, less affected by age-
at-injury than cognitive functions. Indeed, even in the case of unilateral neonatal motor 
cortex injury, which does allow more extensive recovery than bilateral injury, there are 
still significant motor deficits (e.g., Castro, 1990; Kartje-Tillotson, Neafsey, & Castro, 
1985; Whishaw & Kolb, 1988). Thus, our finding that FGF-2 increased performance of 
lesioned rats on the skilled reaching task is very encouraging. 
A number of factors could explain the FGF-2 effect. For example, it is possible 
that FGF-2 acts on the cascade of events that already occurs following damage. Wei et 
al. (2000) found an increase in FGF-2 expression in the frontal cortex and striatum 
following middle cerebral artery occlusion in rats. They suggested that this increased 
expression of FGF-2 likely served to protect neurons following focal ischemia. Previous 
work from our lab has shown that the medial frontal lesioned P10 rats display an 
enhanced behavioural recovery, as well a filling of the lesion cavity (Kolb et a l , 1998). 
Recently, FGF-2 was proposed to account for this recovery (Gibb & Kolb, 2005). It thus 
is possible that peripheral administration serves to 'amplify' the FGF-2 cascade that 
occurs following injury and provides support to the remaining cells. It also could be the 
case that FGF-2 repairs the lesioned area by mobilizing cells from a distant location such 
as the subventricular zone to the site of damage, much as in the spontaneous regeneration 
after mPFC lesions on P10. The newly generated cells could either participate directly in 
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No Lesion Lesion 
Figure 3- 6. Effect of postnatal day 10 motor cortex lesion and/or FGF-2 administration 
on the dendritic length, cell complexity, and spine density of medium spiny neurons of 
the striatum. Overall, striatal cells from the lesioned (gray) rats had longer (A) and more 
complex branches (B) than the non-lesioned rats (white). Those groups did not differ 
with respect to spine density (C). There were no FGF-2 effects or Lesion X FGF-2 
interactions. 
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functional recovery by forming connections with the rest of the brain, or indirectly by 
providing some type of trophic support that facilitates function in the nearby intact brain. 
There is some evidence in the literature suggesting that incremental administration of 
FGF-2 following injury can lead to an increase in cell proliferation (Matsuoka et al., 
2003). It is also possible that FGF-2 simply acts on completely different brain regions 
that provide compensation, such as the anterior cingulate corticospinal projections. A 
combination of these scenarios likely accounts for the changes observed. 
Mapping of the filled lesion cavity suggests that stimulation could elicit 
movements from a number of sites, although forelimb movements were sparse at the 
stimulation intensities used here. The fact that any movements at all could be elicited (in 
the present case, mostly vibrissae movements), however, is of some interest, and at the 
very least suggests that there are cells in a brain region that would otherwise be largely 
absent (without the administration of FGF-2), and that such cells are functional. The fact 
that most of the elicited movements were from the vibrissae is puzzling and may 
represent some fundamental difference in the organization of vibrissal and forelimb 
movements or it may be related to the stimulation parameters. Certainly, the 
corticospinal projections related to forelimb movements are much longer, and may be 
more difficult to develop after neonatal injury. Thus, it may require a recruitment of 
more fibers, possibly with more intense stimulation, to observe more ICMS-related 
forelimb movements. One difficulty with the ICMS experiment is that this technique is 
performed by lowering a micro-electrode into layer V of the motor cortex, then sending a 
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small amount of current that activates horizontal networks of corticospinal neurons, 
which in turn elicits movements (Jankowska, 1975). In the present case, it is possible 
that although we thought we were stimulating layer V neurons, we were in fact not 
adequately targeting the appropriate networks necessary to elicit forelimb movements. 
We chose to limit deviations to the ICMS protocol to a minimum, because the technique 
itself can induce plastic changes within motor cortex (Nudo et al., 1998; Monfils, Plautz 
& Kleim, 2005). Furthermore, we wanted to ensure that our stimulation did not spread 
beyond the boundary of the regrown tissue and into the intact brain, when stimulating the 
filled region. Thus, it is possible that different stimulation parameters, or stimulation 
through different depths may have yielded more forelimb responses. It is also possible 
that a higher intensity of stimulation would have been more effective in eliciting forelimb 
responses. We chose not to use intense stimulation parameters, however, because it 
would have been difficult to compare the maps in control and lesion rats. Had we 
increased the intensity in the controls we would have activated a broader pool of neurons, 
which would have produced larger maps in the control rats. Thus, we chose to keep the 
intensity constant to allow for a more appropriate comparison. Finally, motor cortex 
mapping using ICMS relies on the subjective perception of movements. It is possible 
that such a method was not sensitive enough to detect subtle activation of the muscles 
upon stimulation of the filled cavity. 
The absence of the rostral forelimb area in all animals with motor cortex lesions is 
curious given that the lesions would likely not have removed this region. It is possible 
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that one effect of the lesion was to produce a large-scale reorganization of the motor map. 
We did map well beyond the motor area and in some animals much of the hemisphere 
was stimulated but no anomalous map was seen. It thus seems unlikely that rostral 
forelimb areas simply relocated to some intact cortical region. 
Our results do not conclusively demonstrate exactly how the FGF-2 treatment 
leads to better functional outcome. We have shown previously that neutralizing 
antibodies to FGF-2 block recovery in rats with motor cortex lesions in adulthood, and 
this was correlated with dendritic atrophy in the perilesional cortex (Rowntree & Kolb, 
1997). Thus, it is possible that the FGF-2 treatment had the opposite effect here and 
acted on the neural networks in perilesional cortex. The absence of ICMS-positive sites 
in perilesional cortex does not support this idea. A second possibility is that FGF-2 
increased neuro- or gliogenesis both in the region of the lesion cavity and elsewhere in 
the brain. We have obvious evidence of new cells in the lesion cavity but have no 
measure of cell generation elsewhere. Nonetheless, we believe that taken together, our 
behavioral and ICMS results support the conclusion that at least some of the cells that 
filled the lesion cavity contributed to motor function and are responsible, at least in part, 
for the functional improvements after FGF-2 treatment. This can be tested directly by 
either removing the new tissue or by preventing the generation of the new tissue. We 
have previously shown, in parallel studies in rats with medial prefrontal lesions on day 
10, that removal of the spontaneously generated neurons that fill the lesion area reverses 
the behavioral benefits (Dallison & Kolb, 2003) and that prevention of the regeneration 
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by prenatal administration of bromodeoxyuridine blocks the regeneration and the 
accompanying functional recovery (Kolb et al., 1998). Such studies in motor cortex are 
currently in progress. 
Another question that arises from our results relates to the source of the new cells, 
which would most likely be from the subventricular zone, and whether the cells form 
connections with the intact brain. The simplest way to answer these questions is to use 
the mitotic marker bromdeoxyuridine to label subventricular cells the day before surgery 
and then to do both retrograde and anterograde tracing studies in the adult brain. It 
should be possible to double label cells in the regrown tissue and thus support the 
putative role of these cells in recovery. These studies remain to be performed. 
Because we thought it possible for the striatum to subserve some of the recovery 
of function seen in our study, we also investigated the effects of lesion and/or FGF-2 
administration on the dendritic morphology of medium spiny neurons from the striatum. 
The fact that there was an effect of lesion, but no interaction or main effect of FGF-2 on 
any of the measures of dendritic morphology, suggests that changes within the striatum 
alone are likely not responsible for the recovery of function observed in the skilled 
reaching task. The fact that neonatal lesions to the motor cortex led to dendritic 
hypertrophy in the striatum is interesting. Gonzalez & Kolb (2003) reported differential 
changes within the striatum following unilateral injury to the motor cortex inflicted in 
adulthood. Effectively, whereas middle cerebral artery occlusion led to an increase in 
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dendritic arbor in the striatum, aspiration lesion led to a decrease in the same measures. 
This latter result contrasts with the current findings and suggests that changes in striatal 
neurons vary not only with lesion etiology but also with age at injury. 
In sum, our work provides evidence that FGF-2 may play a significant role in 
recovery from early cortical injury. Our findings are in agreement with previous reports 
showing that administration of FGF-2 after cortical injuries on postnatal day 3, as well as 
the administration of treatments that stimulate the endogenous production of FGF-2, can 
positively affect recovery on cognitive tasks (Gibb & Kolb, 2005; Comeau, Hastings & 
Kolb, 2005). In these past studies, however, FGF-2 did not stimulate the filling of the 
lesion cavity. Indeed, to our knowledge, the present study provides the first evidence of a 
treatment that can stimulate functional and physiological recovery following bilateral 
motor cortex damage at any age. We have also found that FGF-2 is ineffective in 
stimulating recovery in adult rats with motor cortex injury (B Kolb, unpublished studies). 
The key difference here is that the injury and subsequent FGF treatments began on day 
10, rather than earlier or later. An important question for future research is to determine 
what is special about day 10 and how we might use this knowledge to stimulate recovery 
at other ages. Additionally, in future studies we should aim to establish whether the 
tissue filling the cavity plays a significant role in mediating the functional improvement 
observed in the lesioned-FGF-2-treated rats. 
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Abstract 
We have recently shown that the application of basic fibroblast growth factor (FGF-2) in 
postnatal 10 (P10) rats with motor cortex (MCx) lesions results in functional 
improvements accompanied with a filling of the lesion cavity with tissue. In contrast, 
lesion rats that do not receive FGF-2 do not show a filling of the lesion cavity and are 
impaired relative to their treated counterpart. The present experiment sought to evaluate 
the electrophysiological and anatomical connectivity of the projections from the tissue 
filling the cortex in lesioned neonatal rats that received FGF-2. To that effect, rats 
received bilateral MCx lesions on P10. Beginning with PI 1, they received subcutaneous 
injections of either vehicle or FGF-2 for 7 days. In adulthood, the physiology of 
presumptive corticospinal projections was evaluated using intracortical microstimulation, 
then recording the evoked electromyographic (EMG) activity in wrist extensors, and 
comparing the delay to elicit EMG activity to that of control rats. The regrown 
corticospinal projections were anterogradely traced using biotin dextran amine (BDA). 
Results revealed that in 5 out of 7 FGF-2 treated lesioned rats, activity could be induced 
in wrist extensors following stimulation of the filled cavity. Furthermore, in the rats in 
which EMG activity could be elicited, long descending axons could be labeled with 
projections into the spinal cord, which showed delays comparable to undamaged 
'cortico'spinal fibers. Together our results suggest that the FGF-2-induced recovery from 
early MCx injury is supported by projections from the filled region. 
Key words: EMG, corticospinal, FGF-2, reaching, motor cortex. 
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Basic fibroblast growth factor (FGF-2) is involved in a number of physiological 
processes including a potential role in regulating developmental processes (e.g., Li & 
DiCicco-Bloom, 2004; Raballo et al., 2000) as well as mediating recovery from injury in 
adult and neonatal animal models of focal brain injury (e.g., Ganat et al., 2002; Rowntree 
& Kolb, 1997; Gibb & Kolb, 2004; Monfils et a l , 2005a). There is evidence suggesting 
that the different spatio-temporal developmental expression of FGF-2 might play a role in 
modulating recovery from cortical damage in neonatal rats (Ganat et al., 2002; Monfils et 
al., 2005a; Gibb & Kolb, 2004). In particular, Kolb et al. (1998) have reported 
spontaneous anatomical and behavioral recovery from medial prefrontal cortex aspiration 
lesions inflicted at postnatal day 10 in rats, and such recovery does not occur if the injury 
occurs earlier in development. Notably, the better outcome coincides with elevated FGF-
2 expression in the cortex (Gibb & Kolb, 2004). Rowntree and Kolb (1997) have also 
shown that blocking FGF-2 following motor cortex lesions in adulthood worsens the 
behavioral outcome and was associated with dendritic atrophy in layer V pyramidal cells 
contralateral to the lesion. FGF-2 blockade also reduces FGF-2 reactivity following a 
unilateral aspiration lesion while preserving normal GFAP reactivity. Together, these 
studies suggest that endogenous FGF-2 plays a critical role in improving outcome 
following injury in neonatal and adult rats. Recently, we investigated whether exogenous 
administration of FGF-2 could be beneficial following aspiration lesions of cortex in 
neonates (see Comeau et al., 2005; Monfils et al., 2005b). We found that FGF-2 
application leads to functional improvement in a reaching task following medial 
prefrontal cortex lesions inflicted at P3 (Comeau et al., 2005). Furthermore, FGF-2 
67 
induces partial recovery of function on a skilled motor task following bilateral motor 
cortex lesions inflicted at P10, accompanied by a filling of the lesion cavity with tissue 
(Monfils et al., 2005b). This result is especially important, considering that motor 
impairments following cortical injuries are quite persistent, regardless of age at injury or 
area damaged (Kolb et al., 2000). Our earlier findings emphasize the therapeutic 
potential of FGF-2 following cortical injuries, yet, the mechanism by which functional 
recovery might be promoted is currently unknown. For example it is uncertain whether 
the tissue filling the cavity directly contributes to functional improvements. 
Understanding the role and functionality of the regrown tissue may provide important 
insight on how to repair the injured central nervous system. A first step in this direction 
is to assess the integrity of connections from this region. We thus sought to evaluate 
whether the filled region where the formerly forelimb area of the motor cortex was 
located, contains neurons capable of activating forelimb muscles as seen in uninjured 
rats. In the present study, we examined the electrophysiological and anatomical integrity 
of regrown cortico spinal projections in motor cortex lesion rats that received FGF-2 to 
assess whether they form functional connections and possibly contribute to the functional 
recovery observed following FGF-2 administration. 
Following bilateral aspiration lesions to the motor cortex at P10, rats received 
exogenous administration of either FGF-2 or BSA (vehicle). In adulthood, functional 
outcome was evaluated by testing the rats' performance on a skilled reaching task. Then, 
the connectivity of the corticospinal projections from the filled cavity was evaluated 
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using microstimulation and recording the electromyographic activity in wrist extensors. 
The anatomy of the regrown projections was assessed by anterograde tracing using biotin 
dextran amine. 
Experimental procedures 
Subjects 
The present study used 24 male rats, derived from the Charles River Long-Evans hooded 
strain, which were divided into groups that received either bilateral motor cortex lesions 
(N=14) or sham operations (N=10) on postnatal day 10. The animals were group-housed, 
and then placed with same sex littermates in clear plastic cages in a colony room 
maintained on a 12 h on/12 h off light cycle. All experimentation was conducted during 
the light phase. Rats were maintained on Lab Diet no. 5001 (PMI feeds Inc., St-Louis, 
MO) and water ad libitum, except during the Whishaw tray reaching task, and were 
handled and cared for according to the Canadian Council for Animal Care guidelines. 
Experimental Design 
Lesion and sham-operated rats were divided into groups that received 7 daily injections 
(s.c.) of either FGF-2 (N=12) or bovine serum albumin (BSA) (N=12). In a previous 
study conducted in our laboratory, this injection protocol was found to be effective in 
promoting behavioral recovery following medial prefrontal cortex aspiration lesions at P3 
(Comeau, et al., 2005), as well as functional improvements accompanied by a filling of 
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the lesion cavity following MCx lesions inflicted at P10 (Monfils et al., 2005b). 
Following injections, the rats were allowed to age until PI00, at which time they were 
trained and tested in the Whishaw tray reaching task for 14 days (Whishaw, 1991). Then, 
the filled region contralateral to their preferred forelimb was electrophysiologically 
assessed using intra'cortical' microstimulation and EMG recordings, and traced using 
biotin dextran amine (BDA, Vector Laboratories, Burlington, ON, Canada). Two weeks 
later the rats were intracardially perfused, and their brains sectioned. One series was 
processed for cresyl violet staining, and another was processed to visualize BDA. 
Materials 
FGF-2 injections 
Basic fibroblast growth factor (FGF-2, R & D systems, Minneapolis, MN #233-FB) was 
diluted in BSA (1 [ig/ml), and administered at 0.1 ml/10 g of body weight per day (for a 
final concentration of 10 ng/g). This was based on the work of Wagner et al. (1999), 
which had shown this concentration to be sufficient to enhance neurogenesis in P7-P28 
rats. BSA (Sigma-Aldrich) was prepared into 0.1 M PO4 as a concentration of 1 mg/ml. 
Lesion Procedure 
P10 rats were anesthetized by cooling in a Thermatron cooling chamber until rectal 
temperature was in the range of 18-20°C. The bone over the motor neocortex area was 
removed with iris scissors and motor decortication was achieved by aspiration using 
70 
procedures described by Kolb (1987). Kolb (1987) previously showed that, on postnatal 
day 1, the frontal cortex lies more anterior relative to bregma than it does in adulthood, 
but that the relation between the bregmoidal junction and the underlying cortex is 
constant after about postnatal day 5. Thus, to completely ablate the forelimb area of the 
motor cortex, the lesion was performed from +2 to - 2 , relative to the bregmoidal 
junction. The control rats were anesthetized, the skin incised, and then sutured with 5-0 
Vicryl thread. 
Skilled Reaching Task 
Forelimb use was measured with a procedure adapted from the method devised by 
Whishaw et al. (1991). Each animal was food deprived to 85 % free feeding level 
throughout training and testing. The rats were placed in the test cages (10x18x10 cm 
high) with floors and front constructed of 2 mm bars, 9 mm apart edge to edge. A 4 cm 
wide and 5 cm deep tray, containing chicken feed pellets, was mounted in front of each 
box. The rats were required to extend a forelimb through the gap in the bars, grasp and 
obtain the food. The tray was mounted on runners and was retracted 0.5 cm from the 
cage so that the rats could not scrape the food into the cage. If the animal attempted to 
rake the pellet out of the tray, the pellet would inevitably fall through the gap. An 
attempt was scored only if the rat reached into the tray and touched the food. If it 
reached into the tray without touching the pellet, no attempt was scored. A successful 
reach was defined as grasping a pellet, and bringing it to the mouth. The rats were 
trained for 20 minutes per day for 14 consecutive days. Once trained, the rats received a 
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10 minute reaching test during which time they were videotaped for later scoring. All 
rats showed a forelimb preference, and only the reaches performed by the preferred limb 
were scored and analyzed. The success score was expressed as a percentage, and was 
computed by dividing the number of successful reaches by the total number of reaches, 
and then multiplying the ratio by 100. 
Intracortical Microstimulation and Electromyographic Recordings 
Two weeks following the last reach training session (to rule out potential effects of 
training and food deprivation [Smith & Metz, 2005]), intra'cortical' microstimulation 
(ICMS) was used and evoked potentials in wrist extensors were recorded. Rats were 
anesthetized with ketamine hydrochloride (70 mg/kg, injected intraperitoneally [i.p.]), 
and xylazine (5 mg/kg, i.p.). Supplementary injections of ketamine (20 mg/kg, i.p.) were 
administered as needed. Teflon coated stainless-steel (Cooner wire Inc Chatsworth, Ca) 
bipolar electrodes with exposed tips of approximately 2 mm were acutely implanted in 
wrist extensors (Raineteau et al., 2001). A craniotomy was performed over the filled 
region (or motor cortex, in controls), and the dura was carefully removed. A tungsten-
wire electrode (approximately 3.5 MOhms) controlled by a manual microdrive was used 
to make approximately 3-5 penetrations to a depth of ~ 1550 urn (corresponding to 
cortical layer V), or to the coordinates corresponding to the dorsolateral striatum (Paxinos 
& Watson, 1992). Stimulation consisted of twenty cathodal pulses, 0.2 ms in duration, 
delivered at 330 Hz from an electrically isolated stimulation circuit to up to 100 uA. The 
EMG signal was amplified (cyberamp, Axon instruments), filtered (20-300 Hz) and 
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digitized at a sampling rate of 5 kHz using the Axoscope program (Axon instruments). In 
the control rats, cortical stimulation was restricted to the caudal forelimb area (CFA). In 
the lesion rats, stimulation was extended to include most of the hemisphere in order to 
assess whether shifts in the motor maps had occurred. EMG recordings were performed 
in 7 lesion and FGF-2-treated animals, 7 lesion and control BSA-treated animals, 5 no 
lesion animals that received FGF-2, and 5 no lesion rats that did not receive FGF-2. 
Analysis of EMG recordings 
The occurrence and the delay of EMG responses was assessed using Axoscope. The 
delay was defined as the time from the first stimulus pulse to the onset of EMG activity. 
A minimum of 10 sweeps of EMG activity was analyzed and averaged for each 
stimulation site. 
Anterograde Tracing (BDA) 
Following EMG recordings, the presumptive caudal forelimb area of motor cortex (in 
controls) (Neafsey et al., 1986; Kleim et al., 1998) and the filled region (Monfils et al., 
2005b) was traced using pressure injection of biotin dextran amine (BDA; 10,000 
molecular weight, Molecular Probes, Eugene, OR). A single stereological injection of 
0.5 ul of a 10% BDA solution in 0.1 phosphate buffer, pH 7.2 was made approximately 
0.5 mm rostral, and 2.0 mm lateral to Bregma at a depth of 1.5 mm, using a 10 uL 
Hamilton syringe fitted with a glass micropipette with an opening of approximately 50 
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um in diameter (Z'Graggen et al., 1998). In the lesion rats that received FGF-2, BDA 
was injected in the filled cavity in a region from which EMG activity could be stimulated. 
Perfusion and histology 
Fourteen days following BDA injection, the rats were intracardially perfused with 0.9% 
phosphate buffered saline followed by 4% PB PFA, and the brains and spinal cords were 
removed and placed in 4%> PFA for 24 hours. They were then transferred to 30% 
buffered sucrose for cryoprotection. The brain, brain stem and spinal cord were 
embedded separately in Tissue Tek and immediately frozen by immersion in -40 degrees 
Celsius isopentane. The brain and brain stem were cut saggitally, a portion of the spinal 
cord was cut horizontally and the cervical (CI) spinal cord was cut coronally. All 
sections were cut at 30 um, and stored in two separate series. The brain and spinal cord 
were cut in different planes to maximize the likelihood of finding labeling in each region, 
as well as to facilitate following the labeled fibers from cortex (or filled cavity) to spinal 
cord. 
BDA Immunohistochemistry 
One series of the sections from all tissue sections was processed for BDA staining. 
Staining for BDA was performed according to earlier reports (Fouad et al 2001). The 
slides were washed 3 x 3 0 minutes in a 50 mM Tris buffered saline, pH 8.0, containing 
0.5% Triton X-100 (TBS) on a magnetic stirrer. Afterwards the slides were incubated 
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over night with an avidin-biotin-peroxidase complex in TBST (ABC elite, Vector Labs, 
Burlingame, CA) according to the instructions of the manufacture. Subsequently the 
DAB reaction was performed using the Vector DAB kit (SK4100, Vector Labs). The 
reaction was monitored and stopped by extensive washing in TBS. The slides were dried 
for two days and dehydrated through alcohol and xylene and coverslipped in Permount 
(Fischer Scientific). The second series of sagittal brain sections was Cresyl violet stained 
to allow us to examine the laminar distribution of cells within the filled region. 
Following staining, the slides were dehydrated in increasing series of alcohol and 
coverslipped. 
Analysis of Anterograde Tracings 
The diffusion of BDA was measured by taking a picture at 50x using a camera mounted 
on a Zeiss microscope of the site across all sections it spread through. The volume of 
BDA diffusion was then calculated using NIH image. The saggital brain and brain stem 
sections, the horizontal spinal cord sections and the spinal cord cross sections were 
examined for the presence of anterogradely labeled fibers, and the cross-sectioned fibers 
from CI were counted. 
Statistical Analyses 
Factorial Analyses of Variance (ANOVAs) were performed and compared the four 
experimental groups on 4 dependent measures: standardized brain size, skilled reaching 
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performance, EMG delay from cortical stimulation, and EMG delay from striatal 
stimulation. A regression was derived to evaluate the relationship between the number of 
fibers counted in the spinal cord and the success rate on the skilled reaching task. 
Significant interactions were followed-up with Fisher's least significant difference tests. 
All statistical analyses were performed using SPSS 11. 
Results 
Gross anatomy of the lesion site 
As in our previous studies, the untreated lesioned rats all showed some degree of 
cavitation at the lesion site in adulthood. In contrast, there was evidence of lesion size 
reduction induced by a partial filling of the lesion cavity in the lesioned rats that received 
FGF-2 (Figure 4-1A and 4-1C). Inspection of the cresyl violet-stained sections revealed 
that in contrast to normal brains in which neurons showed an organized laminar 
distribution, the organization of the filled cavity appeared haphazard. 
Skilled Reaching Task 
The Whishaw tray reaching task is a sensitive measure that evaluates forelimb motor 
function. Here we show an overall effect of lesion on the rats' success in the skilled 
reaching task. As previously reported, FGF-2-treated lesioned rats outperformed their 
untreated no lesion counterparts on reaching success (Figure 4-2). A 2x2 factorial 
ANOVA revealed a main effect of lesion, F(l,15)= 70.157, p< 0.0001, as well as a 
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Figure 4 -1 . Distribution of cells within the filled cavity of rats that received motor 
cortex aspiration lesions at postnatal day 10 and FGF-2 treatment. Lesion rats that did 
not receive FGF-2 show a prominent lesion cavity (not shown here), whereas those that 
were lesioned and received FGF-2 show a filling of the cavity with cells (1 A, 1C). 
Compared to that of a normal rat (IB, ID), the filled region in the lesioned-FGF-2-treated 
rats was disorganized (1A, 1C). 
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significant Lesion x FGF-2 interaction, F(l,15)= 19.203, p<0.0009, on rats' reaching 
success. Statistical follow-up tests revealed no significant difference between the control 
rats that received FGF-2 and those that did not receive FGF-2, p>.05. However, the 
FGF-2-treated no lesion rats performed significantly better than the no lesion animals that 
did not receive FGF-2, p<.05 (Figure 4-2). 
EMG responses from stimulating the motor cortex or filled lesion cavity 
The elicitation of wrist extensor EMG activity following stimulation of the motor cortex 
(controls) or filled cavity (lesioned-FGF-2-treated rats) was assessed to evaluate the 
electrophysiological integrity of projections from the filled region. We found that 
whereas 8 out of 9 control rats showed EMG activity from the wrist extensors in response 
to cortical stimulation, none of the lesion untreated rats showed any EMG activity in 
response to stimulation of areas adjacent to the lesion site (Figure 4-3A). In contrast, 
EMG activity could be evoked in 5 out of 7 of the FGF-2 treated lesion animals following 
stimulation of the tissue filling the cavity. All controls, 2/5 lesion untreated, and 5/7 
lesioned-FGF-2-treated rats showed EMG responses following striatal stimulation (see 
Figure 4-4). Interestingly there was no difference between groups with respect to the 
delay of EMG onset following stimulation of either the cortex (or filled region) (Figure 4-
3B) or the striatum (Figure 4-4B) suggesting a monosynaptic connection between 
neurons filling the lesion cavity, and wrist extensor motoneurons (Figure 4-3B, D, and 
E). 
78 
| No FGF-2 Q FGF-2 
* 
100 n I 1 
Non-lesioned Lesioned 
Figure 4- 2. Effect of postnatal day 10 motor cortex lesion and/or FGF-2 administration 
on the skilled reaching performance. Overall, the no lesion outperformed the lesion rats 
on the skilled reaching task. There was also a lesion X FGF-2 interaction which revealed 
that the lesion rats that received FGF-2 performed better than the lesion rats that did not 
receive FGF-2. 
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BDA tracings 
BDA was injected in the filled region (or motor cortex) to assess the anatomical 
projections of fibers from that area. Analysis of BDA diffusion suggests that in the lesion 
rats that received FGF-2, the injections were limited to the filled cavity (i.e., BDA did not 
diffuse to non lesioned cortical areas). Anterogradely labeled fibers were found in all 
control rats that were injected with BDA, and 6 out of 7 rats that were lesioned and 
received FGF-2 (Figure 4-5). A regression analysis to evaluate the strength of the 
relationship between the number of labeled fibers counted in the spinal cord (CI), and the 
reaching success on the Whishaw tray reaching task, revealed a significant relationship of 
moderate strength, R(16)= .64, p< .05 (Figure 4-6). In addition, a regression for the 
lesioned-FGF-2 treated rats only, revealed a strong significant relationship between the 
variables, R(7)= .80, p<.05, suggesting that number of fibers labeled in the spinal cord 
accounted for 64% of the variability in reaching success. 
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Figure 4- 3. EMG recordings from wrist extensors following cortical stimulation in P10 
motor cortex lesioned rats that received FGF-2 injections. 3A summarizes the number of 
rats in each group from which EMG activity could be recorded in the wrist extensors. 
EMG activity was elicited from cortical stimulation in 8/9 of the control rats and 5 out of 
7 lesion-FGF-2-treated rats. The delay of onset following cortical stimulation was 
compared, and revealed that there were no differences between the groups of rats from 
which EMGs were recorded (3B). In 3D and 3E, representative EMG recordings from a 
control rat (3D) and a lesion FGF-2-treated rat (3E) in response to cortical stimulation 
(3C). 
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Figure 4- 4. EMG recordings from wrist extensors following striatal stimulation in P10 
motor cortex lesioned rats that received FGF-2 injections. 4A summarizes the number of 
rats in each group from which EMG activity could be recorded in the wrist extensors in 
response to striatal stimulation. EMG activity was elicited from striatal stimulation in 9/9 
of the control rats, 5 out of 7 lesioned-FGF-2-treated rats., and 2 out of 5 lesioned rats 
that did not receive FGF-2. The delay of onset following cortical stimulation was 
compared, and revealed that there were no differences between the groups of rats from 
which EMGs were recorded (4B). In 4D and 4E, representative EMG recordings from a 
control rat (3D) and a lesioned FGF-2-treated rat (3E) in response to striatal stimulation 
(3C). 
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Figure 4- 5. Anterogradely traced corticospinal fibers from a lesioned rat that received 
FGF-2 injections. Fibers were found in CI in all injected controls, in 6 out of 7 lesioned-
FGF-2-treated, and in 1 out of 7 lesioned non-treated rats. In 4-5A, BDA labeling at the 
injection site. In 4-5B, labeled cells at the injection site at higher magnification (200x). 
In 4-5C, anterogradely traced fibers in the brain stem, and 4-5D, fibers in a horizontal 
section of the spinal cord. 
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Figure 4- 6. Scatterplot and regression line representing the relationship between the 
number of fibers counted in the spinal cord and skilled reaching ability in control and 
lesion rats that received FGF-2 or vehicle. The black triangles represent control rats that 
received FGF-2. The black squares represent control rats that did not receive FGF-2. 
The grey circles represent lesion rats that received FGF-2. A simple regression revealed 
a significant relationship between the number of fibers labeled in the spinal cord and 
reaching performance (R(16)=: .64, p<.05). The number of fibers in the spinal cord 
accounts for 43% of the variance in reaching success. 
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Discussion 
The current study builds on our earlier findings that following bilateral injury to the 
motor cortex inflicted at P10, FGF-2 leads to filling of the lesion cavity with tissue in 
parallel with improvement in a skilled reaching task. Here, we show that the filled region 
contains neurons that project into the spinal cord. Importantly, these neurons are 
functional as their activation results in the activation of neurons in the cervical spinal 
cord. Furthermore, neither cavity filling, recovery of function, spinal cord projections 
nor evoked wrist extensor EMG activity are present in untreated lesion rats. To our 
knowledge this is the first study to demonstrate corticospinal tract restoration in motor 
cortex lesion rats. Consequently, our results support the idea that the filled region is 
involved in mediating the improvement seen in the FGF-2 treated rats (Monfils et al., 
2005b). 
We recently reported that chronic administration of FGF-2 following bilateral 
lesions to the motor cortex inflicted at P10 led to a partial recovery accompanied by a 
filling of the lesion cavity with some cells (Monfils et al., 2005b). These results raised 
obvious questions: (1) Is the filled region involved in mediating recovery? (2) If the filled 
region is involved, what are the mechanisms by which it subserves the behavioral 
recovery? and (3) where do the cells that fill the cavity come from? A number of factors 
could explain the effect of FGF-2 effect, including that FGF-2 might act on different 
brain regions that provide compensation, such as the striatum or the sensory cortex. Our 
earlier results suggested that the striatum alone was likely not responsible for the 
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functional recovery observed, because hypertrophy of medium spiny neurons in that 
structure occurred in response to motor cortex lesions, but no lesion x FGF-2 interaction 
was observed (Monfils et al., 2005b). The sensory cortex alone (or any other cortical 
regions) is also unlikely to account for the behavioural improvement, because layer V 
microstimulation of cortical areas around the lesion site did not elicit any movements or 
evoked potentials (Monfils et al., 2005b and current experiments respectively). 
In the present study, we demonstrate that the filled region could play a key role in 
promoting FGF-2 induced recovery, as functional neuronal projections from that region 
to the spinal cord and onto motoneurons exist. 
Importantly, in the present study, the same lesioned-FGF-2 treated rats from which 
EMG activity could be elicited also showed anterogradely labeled fibers in the spinal 
cord (with the addition of a rat from which EMG activity could not be evoked, as well as 
improved behavioral performance. Another indication that these reestablished cortical 
projections are involved in the recovery is the finding that the number of fibers counted 
in the spinal cord correlates significantly with the reaching success. Although 
statistically significant the strength of the relationship between those two variables was 
moderate, and this may seem deceiving at first glance: i.e., if the filled region was solely 
responsible for the behavioral recovery, we might expect to see a tighter relationship 
between the two variables. A few reasons can explain this discrepancy: (1) it is 
reasonable to anticipate that other brain regions might at least in part be responsible for 
the functional outcome. Indeed, bilateral motor cortex lesions inflicted at P3, P10, or P90 
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all lead to impairments on skilled reaching ability in adulthood. Compared to P3 and P90 
lesioned rats, the PI 0 group shows some degree of functional recovery, yet, all three 
groups show a prominent lesion cavity (Kolb et al., 2000), suggesting that the partial 
recovery seen in the PI0 lesioned rats is due to compensation from other brain areas. The 
FGF-2 treatment might thus be incremental to the other changes that occur as a result of 
injury at P10, and thus results in a greater degree of recovery. (2) We only injected a 
small amount of BDA to ensure that the injection did not spread beyond the filled region. 
As a result, we likely only labeled a fraction of the total number of fibers. Since we can 
not assume that the cells are evenly distributed with in the regrown tissue, the traced cells 
do not necessarily represent the density of fibers in other regrown areas. 
The mechanisms by which FGF-2 leads to the formation of neurons that extend 
within the filled region with projections into the spinal cord are not clear. A few 
necessary steps are likely involved, a) the cells must migrate to the site of injury, and 
differentiate into neurons, and b) these neurons must grow, extend viable projections and 
make appropriate connections with motor neurons in the spinal cord. 
Past studies have shown that exogenous administration of FGF-2 in adult rats 
induces cell proliferation in the subventricular zone (Tao et al., 1996; Kuhn et al., 1997; 
Wagner et al., 1999), and promote neuronal differentiation (Kuhn et al., 1997). In 
addition, increases in endogenous levels of FGF-2 in response to injury (e.g., hypoxia) 
have been found to be associated with the presence of FGF-2-reactive radial glial cells in 
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the subependymal zone, which are thought to be important in improving anatomical 
outcome following brain injury (Ganat et al., 2002). FGF-2 mRNA was also found to be 
increased following ischemic preconditioning, and to protect the brain from a subsequent 
insult (Matsushima et al., 1998). Future studies are underway to elucidate the 
mechanisms that promote cell mobilization to the site of injury in our model. 
Our study suggests the presence of anatomical and electrophysiological connectivity from 
the filled region to the cervical spinal cord. It is somewhat surprising that the regrown 
fibers project in a similar way to the cortico spinal tract in uninjured rats. How this is 
achieved is not fully understood, however, a number of studies have implicated FGF-2 in 
promoting axonal growth. Kawamata et al. (1997) reported an increase in growth-
associated protein 43 (GAP-43) immunoreactivity, a molecular marker of axonal 
sprouting, in the intact sensorimotor cortex contralateral to cerebral infarcts (induced by 
middle cerebral artery occlusion) following FGF-2 treatment, suggesting that FGF-2 
enhances functional improvement after stroke via stimulation of neuronal sprouting in the 
intact brain. FGF-2 was also found to significantly increase sprouting by the cholinergic 
septodentate pathway following entorhinal cortex injury (Ramirez et al., 1999). In 
addition, FGF-2 has been shown to increase astrocyte-associated fibronectin (Mahler et 
al., 1997), an axonal growth-promoting molecule (Price and Hynes, 1985; Liesi et al., 
1986; Matthiessen et al., 1989). In addition to axonal growth, relevant cues must be 
present in order for projecting neurons to extend their projections to the appropriate 
target, i.e., cervical motor neurons, and the mechanism by which this might occur in the 
current preparation is unknown. Of relevance here, however, FGF-2 signaling is known 
to play a role in axonal guidance to the appropriate target in Xenopus retinal ganglion 
cells in vivo (McFarlane et al., 1995). 
In conclusion, we demonstrate for the first time that following cortical lesions in 
neonatal rats that received FGF-2 the lesioned region fills with cells that contain neurons, 
which project to the spinal cord and make contacts with motoneurons. Thus, the 
presented findings provide a mechanism explaining our earlier findings (Monfils et al., 
2005b) and supports further research in the therapeutic potential of FGF-2. Additional 
experiments are needed to elucidate the source of cells filling the cavity and to derive 
suitable treatments for brain injury inflicted in different regions or developmental time 
points. 
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Abstract 
We have recently shown that postnatal day 10 (P10) motor cortex (MCx) lesioned rats 
that receive basic fibroblast growth factor (FGF-2) following the lesions show partial 
recovery of function accompanied by filling of the lesion cavity with new tissue. The 
primary objectives of the current study were to identify the mechanism by which the 
lesion cavity fills with tissue in response to FGF-2, to evaluate the anatomical and 
neurophysiological integrity of this filled region, and to establish whether preventing the 
filling of the cavity with new tissue would prevent functional recovery. The results show 
that: 1) FGF-2 stimulates neuroblasts from the subventricular region to migrate to the site 
of injury; 2) the cells that fill the lesion cavity show normal-appearing spontaneous 
electrical activity; 3) the cells that fill the cavity form synapses; 4) blockade of neuroblast 
migration by embryonic day 13 injections of bromodeoxyuridine prevents the later FGF-
2 induced filling of the lesion cavity and inhibits functional recovery; and, 5) removal of 
newly generated tissue reversed the functional gains. Taken together, the results suggest 
that after day 10 motor cortex injury exogenous FGF-2 stimulates the brain to produce 
new cells that migrate to the of injury, form synapses and neuronal networks, and 
contribute to motor function. 
Key words: FGF-2, reaching, motor cortex, electron microscopy, ki67, doublecortin. 
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Basic fibroblast growth factor (FGF-2) is involved in regulating developmental processes 
(e.g., Li & DiCicco-Bloom, 2004; Raballo et al., 2000) as well as mediating outcome in 
response to various types of injury (e.g., Ganat et al., 2002; Rowntree & Kolb, 1997). 
There is much evidence suggesting that the developmental expression of FGF-2 might 
play a role in modulating plasticity following cortical damage (Ganat et al., 2002; 
Monfils et al., 2005a). Notably, we have shown in two independent studies that after 
receiving motor cortex (MCx) lesions on postnatal day 10 (P10) Mcx-lesion rats that 
receive FGF-2 perform better on a skilled motor task in adulthood (Monfils et al., 2005b; 
Monfils et al., 2005c). In addition, the lesion-FGF-2-treated rats show a filling of the 
lesion cavity with both neurons and glia. 
Indirect evidence from our prior studies suggests that the filled cavity might be 
involved in the functional improvement observed in the lesion FGF-2-treated rats. 
Specifically, we have shown that stimulation of the filled region leads to EMG activity in 
the forelimb extensors and to the induction of some movements and that cells in the filled 
region have corticospinal connections (Chapter 4). It is unknown, however, whether the 
FGF-2-induced filling of the cavity is necessary for the behavioral improvement. 
Furthermore, the mechanism by which the lesion cavity fills with cells in response to 
FGF-2 treatment is currently unknown. 
The primary objective of the current study was to evaluate the anatomical and 
neurophysiological integrity of the filled region, and to establish whether preventing the 
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filling of the cavity with tissue would prevent functional recovery. A complimentary 
objective was to identify the mechanism by which the lesion cavity fills with tissue in 
response to FGF-2. Four experiments were conducted and were specifically designed to 
(1) identify the types of cells that fill the lesion site, (2) establish whether the cells that 
fill the lesion site show spontaneous electrical activity and to compare the firing pattern 
to that of undamaged rats, (3) estimate the number of synapses from the filled region or 
motor cortex, as well as area Cg3, (4) replicate our prior findings that FGF-2 induces 
functional recovery, and (5) evaluate whether preventing (or removing) the filling of the 
lesion cavity would prevent the functional recovery associated with FGF-2 injections. 
Materials and Methods 
General Experimental Design 
All experiments were performed on rats that received motor cortex or sham 
lesions at postnatal day 10, followed by chronic injections (up to 7 days) of either BSA 
(vehicle) or FGF-2. Experiment 1 investigated the effects of P10 motor cortex lesions 
followed by FGF-2 administration on Ki67 and doublecortin expression in the filled 
region and striatum at PI4, and P21. Experiment 2 looked at the effects of P10 motor 
cortex lesions followed by FGF-2 administration on the firing pattern of cells from the 
adult motor cortex (in control rats) or the filled region (in lesion rats that received FGF-
2). Experiment 3 was conducted on tissue from rats that were used in a prior study 
(Monfils et al., 2005b). Tissue from the motor cortex (controls), the filled region 
(lesion+FGF-2 rats), and area Cg3 (all rats) obtained from one hemisphere was processed 
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for light and electron microscopy, and the number of neurons as well as the number of 
synapses was estimated using unbiaised stereology techniques. In Experiment 4, we 
attempted to prevent the filling of the cavity by injecting rats with BrdU on embryonic 
day 13 (E13). We have shown previously that such treatment blocked both functional 
recovery and the spontaneous generation of cells in rats with medial frontal lesions on 
P10 (Kolb et al., 1998). On P10, these rats received either motor cortex or sham lesions, 
then either BSA (vehicle) of FGF-2 chronic injections (7 days). In early adulthood (P45), 
all rats were trained and assessed on a reaching task. In Experiment 5, 5 control rats and 
5 lesion rats that received FGF-2 (from experiment 4) were assessed in the skilled 
reaching task and the cylinder asymmetry test before and after receiving a unilateral 
lesion to the motor cortex (or filled region) contralateral to their preferred forelimb. 
The rats were group-housed, and then placed with same sex littermates in clear 
plastic cages in a colony room maintained on a 12h on/12h off light cycle. For each 
experiment, testing was conducted during the light phase. Rats were maintained on Lab 
Diet no. 5001 (PMI feeds Inc., St-Louis, MO) and water ad libitum, except during the 
Whishaw tray reaching task, and were handled and cared for according to the Canadian 
Council for Animal Care guidelines. 
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Experiment 1 
Animals 
In Experiment 1, 36 male Long-Evans hooded rats were used and were divided into 
groups that received either bilateral motor cortex lesions (N=12) or sham operations 
(N=12) on postnatal day 10 using a split litter design. 
General Procedures 
The lesioned and sham-operated rats were divided into groups that received up to 7 daily 
injections of either FGF-2 (n=12) or BSA (n=12) administered subcutaneously. Rats 
were perfused and processed for immunohistochemistry at either P14 (n=12), or P21 
(n=12). 
Surgery 
The neonatal rats were anesthetized by cooling in a Thermatron cooling chamber until 
rectal temperature was in the range of 18-20°C. The bone over the motor neocortex area 
was removed with iris scissors and motor decortication was achieved by aspiration using 
procedures previously described by Kolb (1987). The lesion was performed from +2 to 
- 2 , relative to the bregmoidal junction. The scalp wound was sutured with 5-0 Vicryl 
thread as soon as the surgery was complete. The control rats were anesthetized, the skin 
incised, and then sutured with 5-0 Vicryl thread. 
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FGF-2 
Basic fibroblast growth factor (FGF-2) was diluted in Bovine serum Albumin (BSA) (1 
[ig/ml), and administered at 0.1 ml/lOg of body weight (for a final concentration of 10 
ng/g). This concentration was determined based on the work of Wagner et al. (1999), 
which had shown this concentration to be sufficient to enhance neurogenesis in P7-P28 
rats. BSA was prepared into 0.1 M PO4 as a concentration of 1 mg/ml. 
Treatment groups 
The lesioned (n=12) and sham-operated (n=12) rats were divided into groups that 
received 7 daily sessions of either FGF-2 (n=12) or BSA (n=12) administered 
subcutaneously. In a previous study conducted in our lab, this injection protocol was 
found to be effective in inducing behavioral improvement following medial prefrontal 
cortex aspiration lesions at P3 (Comeau, Hastings & Kolb, 2005), and motor cortex 
lesions at P10 (Monfils et al., 2005b). 
Histological Methods and Tissue Preparation 
All rats were sacrificed by overdose of sodium pentobarbitol (100 mg/kg i.p.) and 
perfused transcardially with phosphate buffered saline (PBS; 0.9% saline in 0.1 M 
phosphate buffer) followed by 4% buffered paraformaldehyde. The brains were extracted, 
stored overnight in the perfusate solution, and then transferred to 30% phosphate buffered 
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sucrose. Hemispheres were stereotaxically blocked in the coronal plane, and serial 
coronal sections were cut on a freezing microtome at 40 u.m. 
Doublecortin (DCX) and Ki67 
Sections were incubated overnight (-20 hrs) at room temperature with goat anti-
Doublecortin (DCX, 1:250; Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit anti-
Ki67 (1:250; Novacastra, UK) in 0.3% Triton X in PBS. The sections were then rinsed 
3X in PBS, and placed in a secondary Alexa Fluor 488 anti-goat IgG (1:250) and Cy3 
Conjugated Affinipure Donkey Anti-rabbit IgG (1:250; Jackson Laboratories; West 
Baltimore Pike, PA) for 2 hrs at room temperature. 
Following the labeling procedures, all sections were rinsed in 0.1 M PBS, mounted on 
gelatin/chrome alum-coated slides, air-dried, and cover slipped. DCX and Ki67-labeled 
cells were viewed on a Zeiss Axioskop Z microscope under fluorescence using 5, 10 and 
20X objectives. 
Stereology 
The number of ki67 positive cells were counted within an 82 x 82 pixel grid placed onto 
photomicrographs of the dorsolateral striatum and the dorsomedial striatum. Each grid 
was placed at equidistant locations from the subventricular zone and the callosal white 
matter, which served as landmarks. The exact thickness of each section from all the 
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striatal sections was measured using a programmed z-sectioning routine, and the number 
of ki67 positive cells was expressed per volume (mm 3). 
Experiment 2 
Animals 
The present experiment used 13 male rats, derived from the Charles River Long-Evans 
hooded strain, which were divided into groups that received either bilateral motor cortex 
lesions (N=6) or sham operations (N=7) on postnatal day 10. The animals were group-
housed, and then placed with same sex littermates in clear plastic cages in a colony room 
maintained on a 12h on/12h off light cycle. All experimentation was conducted during 
the light phase. Rats were maintained on Lab Diet no. 5001 (PMI feeds Inc., St-Louis, 
MO) and water ad libitum, except during the Whishaw tray reaching task, and were 
handled and cared for according to the Canadian Council for Animal Care guidelines. 
General Procedures 
The lesion rats received 7 daily injections FGF-2 (n=7), and the sham rats received 7 
daily injections of BSA administered subcutaneously. Following injections, the rats were 
allowed to age until PI00. Then, EEG and multi-unit activity were recorded from the 
motor cortex (in controls) or the filled cavity (in lesion rats that received FGF-2). 
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Surgery 
Bilateral motor cortex lesions were performed at P10, using the protocol outlined in 
Experiment 1. 
FGF-2 
Basic fibroblast growth factor (FGF-2) was diluted in Bovine serum Albumin (BSA) (1 
u.g/ml), and administered at 0.1 ml/lOg of body weight (for a final concentration of 10 
ng/g). This concentration was determined based on the work of Wagner et al. (1999), 
which had shown this concentration to be sufficient to enhance neurogenesis in P7-P28 
rats. BSA was prepared into 0.1 M PO4 as a concentration of 1 mg/ml. 
Field and Single Unit Recordings 
All rats were initially anaesthetized with a combination of isoflurane and oxygen 
(4% isofluorane). A rubber silastic tube cannula was then inserted into the jugular vein 
dorsal to the thoracic cavity, and secured with silk suture thread. The isoflourane/oxygen 
was then discontinued and deep anaesthesia was continued with urethane (0.8 mg/ml) 
administered i.v. through the jugular cannula. Urethane was administered as needed 
throughout the remainder of the surgical procedure. Rats were then placed in a standard 
stereotaxic apparatus. A hole was drilled in the skull above the medial prefrontal cortex 
(A/P: +4.0 mm, M/L: +0.5 mm). Electrodes consisted of insulated and sharpened 
tungsten wire (~1 u-m tip). One electrode was lowered 0.5 - 2 mm into medial prefrontal 
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cortex and was used as a reference. The other electrode ( 0 . 5 - 0 . 8 MQ) was lowered into 
the tissue that filled in the previously aspirated cortex (A/P: +1.0 mm, M/L: 3.0 mm). 
Recorded electrical activity was amplified (1000X) with a Grass QPS11 high 
impedance amplifier/filter (West Warwick RJ, USA). The signal from the electrode 
located in filled in tissue was split and filtered in order to record both field and multiunit 
activity. Field activity was filtered at half amplitude below 0.3Hz and above 100 Hz, and 
multiunit activity was filtered at half amplitude below 100 Hz and above 1 KHz. Both 
signals required the addition of a notch filter at 60 Hz to remove background electrical 
noise. The multiunit activity was displayed on a digital storage oscilloscope (Hitachi 
VC-6023), and also amplified and played through a speaker to aid in the isolation of 
single units. The electrode located in the filled in tissue was moved ventrally in small 
increments, and the visual (oscilloscope) and auditory (audio amplifier and speaker) 
signals were used to aid in the isolation of single unit activity. A cell was considered 
sufficiently isolated when amplitude of the single cell spike was at least twice that of the 
background noise. Once a cell was isolated, 10 minutes of field activity and multiunit 
activity were recorded as separate signals on a Vetter signal recorder/player for 
subsequent off-line analysis. If the signal to noise ratio of the isolated cell was reduced 
below 2:1 during the 10 minutes of recording, the record was discontinued, and isolation 
was attempted again. Following the successful recording of at least 10 minutes of a well-
isolated cell, the reference and cell electrodes were switched. Single cells were then 
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isolated in medial prefrontal cortex so serve as a control example of activity in 
unmanipulated cortex. 
Analysis 
The recorded signals were played back with the Vetter recorder/player into and digitized 
with a Datawave 256 bit analog to digital (A/D) board. The digital signal was analyzed 
using the SciWorks Data Acquisition/Analysis package (Datawave, Denver, CO). The 
field activity was sampled at a rate of 66Hz, and was analyzed for differences in the peak 
frequency. Fourier transforms were performed on several 5-second segments of stable 
EEG collected from both filled in tissue and medial prefrontal cortex. The multiunit 
activity was sampled at a rate of 20 points/ms (20 KHz). Single units were isolated based 
on the peak amplitude of the spike, and comparisons were made for mean firing rate and 
the total firing sum. An inter-event interval histogram was also created in order to 
investigate any gross differences in stationarity or bursting of the isolated cells. 
Histological Methods and Tissue Preparation 
All rats were sacrificed rats by overdose of sodium pentobarbitol (100 mg/kg i.p.) and 
perfused transcardially with phosphate buffered saline (PBS; 0.9% saline in 0.1 M 
phosphate buffer) followed by 4% paraformaldehyde. The brains were extracted, stored 
in the perfusate solution overnight, and then transferred to a phosphate buffered 30% 
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sucrose solution. The brains were blocked in the coronal plane, and serial coronal 
sections were cut on a freezing microtome at 50 urn. 
Experiment 3 
Tissue Samples 
Perfusion and initial fixation 
The tissue samples used in this experiment were obtained from rats that were used in a 
previous study (Monfils et al., 2005b). The brains were processed as follows. All rats 
were deeply anesthetized with sodium pentobarbital (120 mg/kg) prior to perfusion. Rats 
were transcardially perfused with 0.9% saline only. Each brain was cut in front of the 
cerebellum, and mid-saggitally. One hemisphere was immersed in Golgi-Cox solution 
(data previously reported, Monfils et al., 2005d). The other hemisphere was processed 
using a fixation by immersion procedure (Monfils et al., 2005b). The hemisphere was 
immersed in a 37 °C fixative solution containing 0.1 M cacodylate buffer, 2.5% GA, 4% 
PFA and 2.5% dimethysulfoxide (DMSO) for 5 minutes, after which it is transferred to 
the same fixative solution at a temperature of 4° C. This hemisphere was stored at 4° C 
for seven days and then dissected and processed for EM as described below. 
Electron Microscopy Preparation 
The brains were coronally sectioned (300 um) on a vibratome, and the sections viewed 
under a dissecting microscope at low power (2X). Samples of tissue (approximately 500 
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um wide) extending from pia to white matter were dissected from the caudal forelimb 
area of motor cortex using a sharp razor blade. In rats that were lesioned and received 
FGF-2, the 'geographically relevant' area corresponding to motor cortex was dissected. 
For all the groups, area Cg3 was also dissected. The tissue blocks were then processed 
according to the methodology previously reported (Kleim et al., 1996) Briefly, the blocks 
were washed in 0.1 M cacodylate buffer for 2 hours, postfixed in 2% osmium 
tetroxide/1.5% potassium ferrocyanide in 0.1M cacodylate buffer for 2 hours and en bloc 
stained with 2% uranyl acetate for 45 min. The samples were then dehydrated through an 
ascending series of ethanol concentrations before being transferred into propylene oxide 
followed by gradual embedding in Eponate resin. 
A few (approximately 10) 1 um sections were cut from a block of embedded 
tissue from each rat. Sections were stained with toluidine blue, and cortical layer V was 
identified by the presence of large pyramidal cells and the absence of layer IV granule 
cells using the light microscope. Next, most of the block was trimmed away in a 
pyramidal shape, leaving a small strip containing layer V of the motor cortex. From this 
strip, silver/gray serial sections (approximately 70 nm thick) were cut using a diamond 
knife. These sections were collected on Formvar-coated, slotted, copper grids, and 
stained sequentially with uranyl acetate followed by lead citrate. 
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Stereology 
Thin sections were surveyed with the electron microscope and an area of the neuropile 
that was essentially free of nuclei was selected in one of the serial sections. Within this 
area, a composite of four micrographs were taken at X 6,000 such that each micrograph 
represented one quadrant of a square. Next, the same area in a non-consecutive section 
(i.e. the intervening section was skipped) was photographed at the same magnification. A 
minimum of 16 micrographs were prepared for each area dissected for each rat. The 
resulting negatives were then printed at a final magnification of X 23,800 and 
subsequently analyzed for synaptic density using the physical disector method (Sterio, 
1984). In this method, an unbiased counting frame of known area (105 um2) is placed 
over each micrograph of the first composite (reference sections) and the number of 
synapses counted. The same frame is then placed over each micrograph from the second 
composite (lookup sections) and synapses not visible in the reference section are counted. 
In this way, synapses are counted only once. In the present study, synapses were 
identified by the presence of synaptic membrane specializations and only those with at 
least three vesicles were included in the counts. From these counts, the synaptic density 
per volume (um3) could be determined. 
Experiment 4 
Animals 
Seven pregnant rats, derived from Charles River Long-Evans strains, were randomly 
chosen to receive injections of BrdU at embryonic day 13 (4 rats) or to receive no 
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Surgery 
injection (3 rats). Two injections (spaced 6 hours apart) of 60 mg/kg of BrdU in 0.007N 
NaOH, or vehicle, were given intraperitoneally. All rats were then left to continue their 
pregnancy naturally. Postnatally, approximately half the rat pups from each litter were 
given bilateral motor cortex lesions at ten days of age. In a prior study, we found that 
animals with P10 frontal lesions after BrdU injections on El 3 showed no filling of the 
lesion cavity whereas non-BrdU injected rats show a spontaneous filling of the cavity 
(Kolb etal., 1998). 
After weaning, the rats were housed in pairs in shoebox cages where they were 
maintained on a 12:12 h light/dark schedule. Food and water were provided ad libitum 
except during the reaching task where they were food deprived to no less than 85% their 
original body weight. The body weights of all animals were recorded daily for the first 3 
weeks postnatally and then weekly until behavioral testing was completed. 
General Procedures 
The BrdU- (N=17) and non-BrdU-exposed (N=25) lesioned and sham-operated rats were 
divided into groups that received 7 daily injections of either FGF-2 (n=22) or BSA 
(n=19) administered subcutaneously. Following injections, the rats were allowed to age 
until P65. Then, all rats were trained and assessed on the Whishaw tray reaching task. 
The BrdU-exposed rats were then perfused. The non-BrdU-exposed rats were further 
tested in Experiment 5. 
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Bilateral motor cortex lesions were performed at P10, using the protocol outlined in 
Experiment 1. 
FGF-2 
FGF-2 was prepared and administered using the same protocol as that outlined in 
Experiment 1. 
Whishaw tray reaching task 
Forelimb use was measured with a procedure that was adapted from the method devised 
by Whishaw et al. (1991). Each animal was food deprived to 85 % free feeding level 
throughout training and testing. The rats were placed in the test cages (10X18X10 cm 
high) with floors and front constructed of 2 mm bars, 9 mm apart edge to edge. A 4 cm 
wide and 5 cm deep tray, containing chicken feed pellets, was mounted in front of each 
box. The rats were required to extend a forelimb through the gap in the bars, grasp and 
obtain the food. The tray was mounted on runners and was retracted 0.5 cm from the 
cage so that the rats could not scrape the food into the cage. If the animal attempted to 
rake the pellet out of the tray, the pellet would inevitably fall through the gap. An 
attempt was scored only if the rat reached into the tray and touched the food. If it 
reached into the tray without touching the pellet, no attempt was scored. A successful 
reach was defined as grasping a pellet, and bringing it to the mouth. The rats were 
trained for 20 minutes per day for 14 consecutive days. Once trained, the rats received a 
10 minute reaching test during which time they were videotaped for later scoring. All 
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rats showed a forelimb preference, and only the reaches performed by the preferred limb 
were scored and analyzed. 
Experiment 5 
Animals 
From the non-BrdU-exposed rats of Experiment 4, the control rats, as well as lesion rats 
that received FGF-2 were used for Experiment 5. 
Experimental Design 
At P90, an additional baseline measure of the reaching success on the Whishaw tray 
reaching task was obtained on control rats, as well as those that received a lesion+ FGF-
2. In addition, these rats were tested in the cylinder apparatus, to derive a measure of 
asymmetry. Then, all rats received a unilateral motor cortex lesion contralateral to their 
preferred limb. In the lesion rats that received FGF-2, we aimed to remove the filled 
region. Two days following the lesion, all rats were retested in the Whishaw tray 
reaching task and the cylinder apparatus. 
Whishaw tray reaching task 
The rats were assessed on tray reaching task during a single 10 minute-session before the 
lesion, and a single 10 minute-session 2 days following the lesion. The reaching task was 
described in the methods for Experiment 4. 
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Cylinder 
The cylinder (30 cm high, 16 cm dia) of 3-mm-thick Plexiglas was mounted on a glass 
table, beneath which was positioned an inclined mirror. The test consisted of placing a rat 
into the cylinder and leaving it to explore for 5 min during which its behavior was filmed. 
Each contact of a forepaw with the cylinder wall during rearing was measured upon 
replay of the videotape. In addition, the duration of the first 10 contacts for each forelimb 
was timed. An asymmetry score was derived by calculating the number of contact from 
the reaching forelimb. divided by the total number of contacts made by both limbs 
multiplied by 100. 
Results 
Experiment 1 
Doublecortin and Ki67 
In the lesion rats that received FGF-2, the lesion cavity shows a number of migrating 
neuroblasts (doublecortin positive- DCx +) as well as cycling (ki67+) cells at the site of 
injury at P14 as well as P21. In comparison, the lesion rats that did not receive FGF-2 do 
not show cells migrating to the site of injury (see figure 5-1). Analyses were performed 
to quantify and compare the number of cells in the dorsolateral and dorsomedial striatum 
in lesion rats that received FGF-2, lesion rats that did not receive FGF-2, as well as the 
non-lesion matched controls. Two 2x2x2 ANOVAs with age, FGF-2 treatment, and 
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Figure 5-1 . The lesion rats that did not receive FGF-2 (A and B) do not show cells 
migrating to the site of injury. In comparison, in the lesion rats that received FGF-2 (C, 
D, and E), the lesion cavity shows a number of migrating neuroblasts (doublecortin 
positive- DCx +, in green) as well as cycling (ki67+, in red) cells at the site of injury at 
P14aswell as P21. 
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lesion condition as between subject factors were conducted to compare the groups on the 
number of ki67 cells in dorsolateral striatum, dorsomedial striatum. Our analyses 
revealed a main effect of age on both measures, F(l,28)= 11.72, p<.005, F(l,28)=19.921, 
p<.005, for the dorsolateral and the dorsomedial reigons, respectively. This suggested a 
decrease in the number of ki67 positive cells in P21 rats compared to P14 rats. There was 
also a main effect of lesion, F(l , 28)= 9.858, p<.005, F(l,28)= 11.634, p<.05, and an age 
by lesion interaction on both measures, F(l,28)= 4.235, p<.05, F(l,28)= 4.036, p=.05. 
Simple main effects were then conducted for each of the age groups, and revealed an 
effect of lesion on number of ki67 positive cells in both areas investigated, p<.05, 
suggesting an increase in the number of proliferating cells in the dorsolateral striatum and 
dorsomedial striatum of lesion rats. In addition to those regions, a number of ki67 
positive cells were found in the filled cavity at both PI4 and P21. Due to a rather large 
number of doublecortin cells, and the difficulty this created in dissociating individual 
cells, we only discuss these results in qualitative terms. A large number of doublecortin 
positive cells was found in the subventricular zone of all rats at both P14 and P21. There 
was a qualitatively larger amount in the lesion rats, and no apparent differential effect of 
FGF-2. 
Experiment 2 
EEG and multi unit recordings 
We were able to acquire multi unit activity and EEG recordings from the filled region in 
6 out of 7 rats that were lesioned and received FGF-2, and in all control rats. In 1 out of 
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Figure 5- 2 Effects of FGF-2 and bilateral motor cortex lesions at postnatal day 10 on 
the number of ki67-positive cells in the dorsolateral and dorsomedial striatum at P14 and 
P21. There was a main effect of lesion for both P14 and P21 rats, suggesting the PI 0 
motor cortex lesion induced an increase in the number of proliferating cells. 
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Figure 5- 3 Fourier Transform analyses from field EEG recorded from controls and 
lesion rats that received FGF-2. For all rats, there was attenuation of higher frequencies. 
Represented here are data from delta range (A and B) as well as theta, and alpha (C and 
D) for the lesioned rats that received FGF-2 (B and D) and control rats (A and C). 
Overall, the analyses revealed a higher power from the control rats than their lesioned 
counterpart. Importantly, however, the frequency distribution was qualitatively similar. 
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Figure 5- 4 In A, Example of multi-unit activity recorded from a lesion rat that received 
FGF-2. In B, example of one spike from a cell. Multiunit activity was recorded in 6 out 
of 7 lesioned-FGF-2 treated rats and in all controls (6 rats). Analyses revealed that the 
mean firing rate was greater in the cells from motor cortex (controls) than in the cells 
from the filled cavity (lesion rats that received FGF-2) (C). 
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7 lesion-FGF-2 rats, we lowered a recording electrode though dura in the region where 
we expected the filled cavity to be, and were unable to record any unit activity. When 
this rat was perfused, we found a prominent cavity at the lesion site. Fourier Transform 
analysis was performed on the EEG signal acquired from all the rats. A t-test was 
performed to compare the mean firing rate of cells from a control rat and those from the 
region filling the lesion cavity, and revealed a lower spontaneous firing rate of the cells 
from the filled cavity, t(27)= 2.57, p=.016. A qualitative comparison of the Fourier 
Transform performed on EEG from control rats and from lesion rats that received FGF-2 
showed that the pattern of EEG, which was mostly low-voltage fast activity, was similar 
across both groups. Upon closer scrutiny, however, the power associated with peak 
frequencies in the delta, alpha, and beta range was lower in the EEG recorded form the 
filled region compared to that recorded from the control rats, p<.05. EEG and multiunit 
activity were also obtained from a control region (medial prefrontal cortex) in both the 
control and the lesion rats that received FGF-2. Our analyses showed that there was no 
difference between the groups on either the mean firing rate (data not shown), p>.05, or 
the Fourier Transforms for the gamma or the alpha and beta frequency range, p> .05 in 
both cases (data not shown). 
Experiment 3 
Number of synapses per neuron in the motor cortex or filled region 
The filled-in region is not nicely laminated as in normal cortex (Monfils et al., 2005b), a 
finding that led us to wonder if the synaptic density was abnormal as well. A one-way 
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ANOVA was performed to compare the control groups and the lesion rats that received 
FGF-2 on synaptic density, neuron density, and number of synapses per neuron in the 
filled region. Our analyses revealed that the lesioned rats that received FGF-2, the no 
lesion rats that received BSA and the no lesion rats that received FGF-2 did not differ on 
either of these measures, p>.05 (see Figure 5-5). 
Number of synapses per neuron in area Cg3 
Although the major corticospinal projection in the rat is from the motor cortex, there is 
also a projection from anterior cingulate cortex, Zilles' area Cg3. Because this region 
could potentially support recovery of motor function after motor cortex injury, we asked 
whether there were changes in synaptic density in Cg3. A 2X2 factorial ANOVA was 
performed to compare the groups on synaptic density, neuron density, and the number of 
synapses per neuron in area Cg3 between our lesion and FGF-2 groups, and revealed no 
significant lesion X FGF-2 interaction, main effect of FGF-2, or main effect of lesion on 
synaptic density or neuron density, p>.05 (see Figure 5-6). In addition, there was no 
interaction or main effect of FGF-2 on the number of synapses per neuron, p>.05. There 
was, however, a main effect of lesion on the number of synapses per neuron, 
F(l,17)=8.192, p=.019, suggesting that the lesion induced a decrease in the number of 
synapses per neuron in area Cg3. 
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Figure 5- 5. Comparison between controls, and lesion rats that received FGF-2 on 
neuron density, synapse density and number if synapses per neuron in motor cortex or 
filled region. There was no difference between the controls or the lesion rats that 
received FGF-2 in either Neuron density (A), Synapse density (B), or number of synapses 
per neuron (C) in the motor cortex or filled region. There was a main effect of lesion on 
the number of synapses per neuron in area Cg3 (F), p<.05. 
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Figure 5- 6. Comparison between controls, and lesioned rats that did not receive FGF-2 
and those that received FGF-2 on neuron density, synpase density and number of 
synapses per neuron in area Cg3. There was no difference between the controls or the 
lesioned rats that received FGF-2 in either Neuron density (A) or Synapse density (B). 
There was a main effect of lesion on the number of synapses per neuron in area Cg3 (C), 
p<.05. 
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Figure 5- 7. Effects FGF-2 on the skilled reaching performance of El 3 BrdU (or 
saline)-exposed rats that received a bilateral motor cortex-lesion on postnatal day 10. In 
rats exposed to Saline on El3 , FGF-2 administered following a bilateral lesion to the 
motor cortex is associated with an improved outcome on the skilled reaching task (A). In 
the lesion rats that were exposed to BrdU on E l3 , a prominent lesion cavity was present 
even in the FGF-2 treated group. In rats exposed to BrdU on El3 lesion rats are 
significantly impaired on the skilled reaching task, whether they receive FGF-2 or not 
(B). 
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Experiment 4 
Skilled Reaching 
As in our previous studies, FGF-2 treatment enhanced performance on a skilled reaching 
task but this improvement was blocked by prenatal treatment with BrdU. A 2x2x2 
factorial ANOVAs was computed to compare the percent success on the skilled reaching 
task and revealed a 3-Way interaction (BrdU-treatment X lesion X FGF-2 treatment), 
F(l,35)= 6.062, p=.019 (see Figure 5-7). Follow-up tests revealed that in the rats that 
were not exposed to BrdU, whereas there was no difference between the BSA and FGF-
2-treated rats that did not receive a lesion, the lesion rats that received FGF-2 
outperformed their non-FGF-2-treated lesion counterpart, F(l,20)= 4.063, p<.05. In 
contrast, there was no effect of FGF-2 in the BrdU-treated rats, regardless of whether or 
not they were lesioned, p>.05. Finally, as in our previous studies, there was a main effect 
of BrdU, suggesting there was a deleterious effect of BrdU on performance on the skilled 
reaching test, F(l,35)= 33.836, p<.001. In addition, there was a main effect of lesion, 
suggesting that overall the lesion rats did not perform as well as their no lesion 
counterparts, 47.709, p<.001. The BrdU-exposed rats that were lesioned did not show a 
filling of the cavity, regardless of whether or not they had received FGF-2. 
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Experiment 5 
Skilled reaching task 
Rats were tested in the skilled reaching task before and after a unilateral lesion to the 
motor cortex (or filled region) at P90. The basic finding was that the FGF-2-mediated 
improvement in skilled reaching was reversed by removal of the filled-in tissue and that 
the performance level of such rats approximated that of untreated control animals that 
received similar-sized motor cortex removals in adulthood. A 2x2 ANOVA revealed a 
main effect of re-lesion, suggesting that all the rats performed more poorly on the 
reaching task following the lesion, F(l ,16)=40 9, p<.001. There was no re-lesion x 
treatment group interaction, or main effect of group, p>.05. 
Cylinder task 
Rats were tested in the cylinder task before and after a unilateral lesion to the motor 
cortex (or filled region) to assess forelimb asymmetry. Our results show that whereas the 
rats did not show an asymmetry before they received a unilateral lesion, both the controls 
and the lesion rats that received FGF-2 made more contacts with the ipsilateral forelimb 
following the unilateral lesion. A 2x2 ANOVA revealed a main effect of unilateral lesion 
on forelimb asymmetry, F(l,16)= 28.57, p<.001. 
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Figure 5- 8. Effect of unilaterally lesioning (re-lesioning) motor cortex contralateral to 
the preferred forelimb on the reaching success in the Whishaw tray reaching task in 
control rats and rats that received FGF-2 treatment following motor cortex lesions at 
P10. The relesion was associated with a skilled reaching deficit in both the controls and 
the lesion rats that received FGF-2, p<.05. In addition, whereas the groups different on 
skilled reaching performance before the re-lesion, they did not differ after the re-lesion, 
p<.05. 
121 
Figure 5- 9. Effect of lesioning (relesioning) on forelimb asymmetry in controls and 
lesion-FGF-2-treated rats. In A, asymmetry score pre and post re-lesion for the control 
and the lesion-FGF-2-treated rats. Following the re-lesion, both groups showed a 
reduced asymmetry score for the forelimb contralateral to the re-lesion., p<.05 In B, 
difference score (pre - post asymmetry score) for the control and the lesion-FGF-2-
treated rats. There were no differences between the 2 groups on the difference score. 
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Discussion 
We have shown previously that FGF-2 administration following bilateral motor cortex 
lesions inflicted at postnatal day 10 results in a filling of the lesion cavity with tissue and 
behavioral improvement on a skilled motor task. In the current study, we show evidence 
that: (1) FGF-2 stimulates neuroblasts from the subventricular region to migrate to the 
site of injury; 2) the cells that fill the lesion cavity spontaneously fire and show 
electrophysiological characteristics qualitatively similar to those from an undamaged 
motor cortex; and, 3) the cells that fill the cavity form synapses. In addition, we 
demonstrate that the FGF-2-induced motor cortex regrowth is necessary for the 
behavioral improvement by demonstrating that preventing the 'regrowth' by blocking 
cortical neurogenesis prevents the functional improvement; and, re-lesioning the regrown 
region contralateral to the preferred forelimb in adulthood reverses the functional 
improvement to the same degree as that of a unilaterally lesioned control. This study is 
the first to provide a detailed analysis of the behavioral, anatomical, and 
electrophysiological characteristics of newly-generated tissue that fills the lesion cavity 
after FGF-2 administration. 
Neurogenesis 
A number of studies have implicated FGF-2 in mediating neurogenesis, proliferation, and 
survival in vivo (Jin et al., 2003; Mehler et al., 2002; Yoshimura et a l , 2001; Cheng et al., 
2001). Endogenous FGF-2 has also been shown to be upregulated in response to cortical 
injury in a number of preparations (e.g., Ganat et al., 2002; Gibb & Kolb, 2005 ). Here, 
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we show an increase in proliferating (cycling-ki67-positive) cells in the SVZ, as well as 
the striatum, in response to the lesion. This is in agreement with previous reports that 
have shown an increase in neurogenesis in the subventricular zone as a result of a cortical 
lesion (e.g., Faiz et a l , 2005; Gotts & Chesselet, 2005; Gotts & Chesselet, 2005b). Other 
studies have also shown increased neurogenesis (e.g., Gotts & Chesselet, 2005b), or 
dendritic hypertrophy (Monfils et al., 2005b) to occur in the striatum as a result of 
cortical injury. It is important to note that in the present study the increased proliferation 
of cells in the striatum occurred for both lesion groups, with no differential effect of FGF-
2. In addition, we show that in lesion rats, FGF-2 leads to the migration of neuroblasts 
(doublecortin-positive) to the lesion cavity. To our knowledge, this is the first report of 
neuroblasts migrating to the site of injury and permitting a replacement of missing tissue 
with viable cells. Our results suggest that whereas the lesion itself leads to the generation 
of new cells in the subventricular zone, without administration of FGF-2, a number of 
them migrate to the striatum, but never leave to rostral migratory stream to be mobilized 
to the injury site. Future endeavors should establish the mechanism by which FGF-2 
administration leads the newly-born cells to migrate to the injury site. Gott & Chesselet 
(2005) have recently observed that the number of blood vessels in the SVZ of animals 
with lesions was highly predictive of the number of cells in the SVZ, and suggested that 
these two processes may be mechanistically linked. FGF-2 is known to exert potent 
effects on endothelial vascular cells (Gospodarowicz et al., 1979; Logan et al., 1992), and 
thus a similar mechanism may be at play in the present case. 
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Firing characteristics 
In adulthood, the cells filling the lesion cavity spontaneously fire. We show that there are 
quantitative differences in the firing pattern of cells from the filled region compared to 
that of a normal control: the mean firing rate was reduced in the lesion rats that received 
FGF-2. In addition, Fourier Transforms from field EEG suggest quantitative differences 
between the EEG of the lesion rats that received FGF-2 and control rats. Importantly, 
however, the qualitative pattern of multi-unit cell firing as well as the Fourier Transform 
analyses revealed a similar qualitative pattern from field EEG as well as cells isolated 
from the filled region of lesioned FGF-2-treated rats. The mean firing rate of isolated 
cells and Fourier Transforms from field EEG recorded in a control region (the medial 
prefrontal cortex) did not differ between the lesion-FGF-2-treated and control rats. Prior 
studies have reported a reduction in multi-unit activity and changes in field EEG in 
response to cortical injury (e.g., endothelin induced middle cerebral artery occlusion; 
Moyanova et al., 2003), as well as a decrease in the mean firing rate of cortical cells in 
response to hippocampal injury (O'Donnell et al., 2002). Our results are in general 
agreement with these findings, in that we show an overall decreased firing rate in the 
cells in the newly generated region. What is not known, however, is what the reduced 
firing rate might mean to the functioning of the cells. 
Synapses in motor cortex, filled region, and Cg3 
Our results suggest that there was no difference between the number of synapses per 
neuron in the filled region vs. motor cortex. Furthermore, there was an overall effect of 
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lesion, independent of FGF-2 treatment, which led to a decreased number of synapses per 
neuron counted in area Cg3. A number of studies have examined the effect of unilateral 
motor cortex lesions (in adulthood) on synapse numbers or dendritic changes in the 
contralateral cortex (Alfred & Jones, 2004; Luke et al., 2004; Hsu & Jones, 2005). 
Recently, Hsu & Jones (2005) reported an increase in the number of efficacious synapses 
on the side contralateral to the lesion that was associated with an enhanced performance 
on a skilled reaching task with the limb ipsilateral to the injury (Hsu & Jones, 2005). 
Unilateral motor cortex lesions induced earlier in development (P1-P10) lead to dendritic 
hypertrophy in areas adjacent to the lesion, as well as the homotopic regions on the 
contralateral side (Kolb et al., 2000). The present study differs from previous ones, 
however, in that we inflicted bilateral damage. We have reported bilateral motor cortex 
lesion-induced changes in dendritic morphology in the striatum (Monfils et al., 2005b), 
and here we show lesion-induced changes in the number of synapses in area Cg3. The 
fact that those changes are not differentially affected by FGF-2 administration suggests 
that they do not support the additional recovery observed in the lesion rats that received 
FGF-2. Instead, we propose that the cells filling the lesion cavity support the functional 
improvement. Our laboratory previously reported that after day 10 medial prefrontal 
lesions the tissue spontaneously partially regrows and that in adulthood, the cells have 
dendritic fields that are similar to those of normal tissue (De Brabander & Kolb, 1997). 
We are unable to do a similar analysis of dendritic organization in the FGF-2-stimulated 
motor cortex growth because the lamination is abnormal and it would be impossible to 
identify comparable cells in normal brains and the filled-in region. Nonetheless, the 
frontal tissue, the FGF-2-generated motor tissue has relatively normal neuronal 
connectivity. 
The newly-generated tissue supports functional improvement 
We demonstrate with two different methodologies that the filled region is responsible for 
the behavioral improvement reported in the lesion rats that received FGF-2. In the fourth 
experiment, we prevented the filling of the lesion cavity with proliferating cells by 
exposing the rats to BrdU on embryonic day 13 (Kolb et al., 1998). This procedure 
interferes with later postnatal mobilization of subventricular neurons both in vivo and in 
vitro and blocks recovery after day 10 medial prefrontal lesions (e.g., Kolb, Pederson & 
Gibb, in submission). Here we show that the BrdU-exposed rats that received bilateral 
motor cortex lesions still showed a prominent lesion cavity, regardless of whether they 
received FGF-2 or not, and this was associated with a decreased performance relative to 
their non-lesion counterparts. One caveat on this finding is that because the BrdU 
treatment has teratogenic effects on the behavior of rats without cerebral injury, the 
behavioral and anatomical effects on the FGF-treated lesion animals is not without 
question (for a review of common symptoms associated with El 3 BrdU toxicity, refer to 
Kolb et al., 1998b). We therefore chose to test the hypothesis that the filled region was 
involved in the functional improvement using a complimentary method. In Experiment 
5, we assessed the skilled reaching performance of lesioned-FGF-2-treated rats and 
control rats before and after a unilateral lesion to the motor cortex (or filled region) 
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normal synaptic density suggests that like rats with spontaneous regrowth of the midline 
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contralateral to their preferred forelimb. The results show that the adult lesion was 
associated with a significant decrease in reaching performance that was equivalent in 
both the control and the lesioned-FGF-2 rats that received unilateral lesions in adulthood. 
Together, these two experiments provide evidence for a role of the filled region in 
supporting the improved functional outcome. Our laboratory has previously shown that 
bilateral removal of the filled region in adulthood (which spontaneously occurs following 
a medial prefrontal cortex lesion inflicted at P10, and is associated with an improved 
functional outcome) induced a functional deficit (Dallison & Kolb, 1998). Thus, we have 
shown after FGF-2-stimulated motor cortex growth as well as spontaneously generated 
medial prefrontal growth that the functional recovery associated with the newly-
generated tissue can be blocked using two complementary methods. We conclude that 
taken together, the studies show that the new cells contribute to recovery of motor 
functions after both types of injuries on postnatal day 10. 
Broader context and general considerations 
We have previously shown that medial prefrontal neonatal injury inflicted between PI 
and P5 results in a dismal functional and anatomical outcome, whereas a similar injury 
inflicted around 10 days of age is associated with a remarkable functional outcome 
associated with a spontaneous filling of the lesion cavity with tissue. This remarkable 
outcome is restricted to injury to midline cortical regions inflicted around P10, and was 
recently suggested to be mediated by FGF-2 (Gibb & Kolb, 2005). In addition, we 
recently reported a differential expression of FGF-2 throughout development (Monfils et 
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al., 2005a) and found that compared to the first postnatal week FGF-2 expression was 
upregulated in the cortex and the subventricular zone between postnatal day 10 and 18. 
Those results suggested an important role of endogenous FGF-2 in modulating outcome 
from cortical injury around day 10. 
The current findings emphasize a role for exogenous administration of FGF-2 in 
promoting a better outcome following injury. This is supported by behavioral, 
anatomical, and neurophysiological evidence, as well as the fact that the cells filling the 
cavity support the functional improvement on a skilled motor task. We have previously 
reported that the tissue filling the cavity lacks an elaborate topographic representation of 
forelimb movements even though stimulation of the tissue induces EMG activity in the 
contralateral forelimb (Monfils et al., 2005c). Future work will aim to enhance functional 
improvement and attempt to stimulate the formation of an integrated network of 
movement representations by combining focused rehabilitative motor training in 
conjunction with the FGF-2 treatment. 
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6. General Discussion 
The goal of the present thesis was to examine brain plasticity in response to two different 
types of experience: exposure to FGF-2 and/or bilateral lesions of the motor cortex at 
postnatal day 10. We set out to examine these questions with four complimentary studies 
that assessed the potential role of FGF-2 in mediating functional improvements, and 
associated structural changes following bilateral motor cortex injury inflicted at P10. 
Background 
The research presented here was a priori driven by two main principles that emerged 
from decades of research on cortical injury: (1) outcome from brain injury varies as a 
function of age; and, (2) outcome from brain injury varies as a function of area damaged. 
Outcome from brain injury varies as a function of age 
Over three decades of research from the Kolb lab (e.g., Kolb, 1995) suggest that 
regardless of cortical area damaged, a focal aspiration lesion inflicted around postnatal 
day 10 (PI0) is associated with a better functional outcome than a lesion inflicted either 
before or after that time. The better functional outcome is correlated with anatomical 
changes, with the details depending upon the precise region injured. 
Outcome from brain injury varies as a function of area damaged 
Although the functional recovery is overall better at P10, it is clear that the functional 
outcome differs depending on area damaged. Research suggests that the midline 
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structures, i.e., cingulate cortex and medial prefrontal cortex, display a remarkable 
functional and anatomical recovery following a lesion. In contrast, lesions to the more 
lateral cortical regions, i.e., motor cortex and parietal cortex, do not show as pronounced 
a functional recovery (e.g., Gonzalez, Whishaw & Kolb, 2003; Kolb, Cioe & Whishaw, 
2000). 
In an attempt to isolate a shared factor underlying both of these principles, Gibb & Kolb 
(submitted) conducted experiments in which they attempted to find a molecular 'stamp' 
common to mPFC and P10 that could potentially explain the improved functional and 
anatomical outcome relative to other times or regions. They looked at a number of 
potential proteins, and found that a particular growth factor, basic fibroblast growth factor 
(FGF-2), was more highly expressed after P10 than P3 injury to the mPFC. They 
proposed that an increased FGF-2 availability could play an key role in the improved 
behavioral and anatomical outcome observed in rats with P10 mPFC lesions. 
The idea that FGF-2 per se might play a role following injury was not new. A number of 
studies reported a beneficial role of exogenous FGF-2 administration following injury 
(e.g., Comeau et al., submitted; Monfils et al., 2005a). Others reported an upregulation of 
FGF-2 in response to an ischemic insult (e.g., Ganat et al., 2004), and others 
demonstrated that blocking FGF-2 following injury worsens outcome (Rowntree & Kolb, 
1997). The fact that endogenous FGF-2 availability at a certain time and place (P10, 
mPFC) might foster an amazing behavioral recovery, however, was novel, and raised 
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important questions. In particular, if the presence of FGF-2 is one of the 'conditions' that 
fosters a better outcome, could it be applied to induce recovery at different times or after 
injury to different regions? 
Comeau et al. (2005) answered the first question in an experiment in which they 
evaluated whether exogenous administration of FGF-2 could improve the outcome 
following a bilateral P3 lesions to the mPFC (Comeau et a l , 2005). Their results showed 
that FGF-2 induced a behavioural improvement on cognitive tasks, associated with 
structural changes in areas adjacent to the lesion. This lent further support for a role of 
FGF-2 in mediating recovery after brain damage. 
In an attempt to further elucidate whether this new found 'condition' could be applied to 
animals with injury to a different brain region, we sought to establish whether exogenous 
administration of FGF-2 could improve outcome following bilateral aspiration lesions to 
the motor cortex. We chose to perform bilateral lesions to motor cortex for two reasons. 
First, although rats with P10 motor cortex lesions show a better outcome than animals 
with day 1 or adult lesions, they are still profoundly impaired at skilled motor tasks (e.g., 
Kolb, Cioe & Whishaw, 2000). Second, we made bilateral rather than unilateral lesions 
because we wished to ensure that any enhanced motor function was not due to changes in 
the normal hemisphere of unilaterally-injured animals. 
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The results of our first study suggested that the distribution and phenotypic expression of 
FGF-2 during early development provided a possible mechanism by which P10 may 
benefit from a better outcome following injury (Study 1). In our second study, we found 
that FGF-2 administration following P10 lesions to the motor cortex (MCx) leads to 
behavioral improvement associated with a filling of the lesion cavity with some tissue 
(replicated in Studies 3, and 4). The fact that cells filled the cavity in FGF-treated 
animals was unanticipated and played a very important role in shaping the remaining 
studies in this thesis. A strong focus of studies 3 and 4 was to assess the integrity of the 
filled region using a combination of techniques. We also sought to assess how adjacent 
areas were modified in response to the MCx lesion and/or FGF-2 compared to control 
animals, as well as to establish whether the filling of the cavity was necessary for the 
functional improvement on a skilled reaching task. 
We found that stimulation of the filled region elicits a modest number of observable 
movements (Study 2) as well as EMG activity in the wrist extensors (Study 3). 
Furthermore, FGF-2 administered following P10 lesions to the MCx leads to the 
migration of neuroblasts to the site of injury (Study 4), and blocking the filling of the 
lesion cavity prevents anatomical and functional recovery (Study 4). 
In order to understand our results in the broader context of brain plasticity after perinatal 
injury, we must first revisit what 'typically' underlies functional recovery following 
injury to the brain. Specifically, if recovery or compensation on a behavioral task is 
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observed after cerebral injury, the functional change typically is associated with structural 
changes in the remaining brain. We might expect to see one or a combination of three 
different types of changes to occur as a result of focal injury, some resulting in a positive 
outcome and some that do not. First, novel circuitry may be generated and reorganized 
across broad regions of the remaining cortex. Second, following a lesion, the local 
circuitry of the remaining cortex may reorganize. Such changes typically would involve 
reorganization of areas adjacent to the insult, or of other cerebral areas typically involved 
in supporting the behaviour. Third, there may be generation of new glial cells and/or 
neurons, with or without mobilization of those cells to the site of injury. These changes 
in cerebral organization occur following various types of injury, and typically are 
associated with differential functional outcomes. For example, following PI lesions to 
either frontal or parietal cortex, there is extensive reorganization of corticocortical and 
corticostriatal connections (Kolb, Gibb, and van der Kooy, 1994). The reorganization 
involves the formation (or maintenance) of aberrant connections, such as projections 
from the medial geniculate nucleus to the visual cortex, and are associated with a poor 
functional outcome. In contrast, however, when similar lesions are applied to the frontal 
or parietal cortex at P10, there is no evidence of extensive aberrant connections, and there 
is a better functional outcome (Kolb, Gibb and van der Kooy, 1994). A similar 
phenomenon occurs as a result of bilateral motor cortex injury inflicted at different times 
throughout development. PI injury results in the presence of extensive abnormal 
connections from cortical areas adjacent to the injury and is associated with a poor 
functional outcome, whereas P10 injury is not associated with the presence of abnormal 
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connections, and animals with P10 lesions show a better outcome than animals with PI 
lesions (Kolb et al., 2000). 
P10 mPFC lesions are associated with increased dendritic arbor and spine density in areas 
both adjacent to the injury as well as more distally. That is, there are modifications to the 
internal circuitry of the remaining cortex. In contrast, PI mPFC lesion rats show a 
decrease on those same measures. Together, these findings suggest that whereas 
extensive aberrant reorganization of connections hinders function, changes to the intrinsic 
circuitry of the cortex are far more beneficial. 
The last type of change that may occur as a result of injury is neuro- and/or gliogenesis. 
Kolb and colleagues (e.g., Gonzalez et al., 2003; Kolb et al., 1998) have found in a 
number of studies that removal of midline structures (olfactory bulbs, mPFC, Cg) at P10 
results in a spontaneous filling of the lesion cavity with neurons and glia and that the 
presence of this tissue is associated with a remarkable functional recovery. The role of 
cell genesis after medial prefrontal cortex lesions has been most extensively studied, and 
the results suggest that the tissue filling the cavity comprises newly generated neurons 
and glial cells. Blocking the regeneration by administering BrdU on El3 inhibits the 
functional recovery, and removing the tissue filling the cavity in adulthood induces a 
functional deficit (Dallison & Kolb, 2004), lending support to the idea that the filled 
region supports functional recovery. Retrograde tracing from the striatum indicates that 
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the connectivity of the filled region is not abnormal, although it lacks long descending 
corticospinal projections (Kolb et a l , 1998). 
The behavioural and anatomical results presented in the present thesis (bilateral motor 
cortex lesions, and FGF-2) are reminiscent of the changes seen following P10 mPFC 
lesions. Together, the mPFC and Motor cortex studies constitute the only two instances I 
am aware of that suggest that new tissue might be responsible for subserving functional 
recovery after perinatal brain injury. 
In both models, the injury is associated with a filling of the cavity with some tissue, this 
'regrowth' supports the improved functional outcome, and there is no evidence of 
aberrant connections between cortical regions. In both cases, there are cells firing from 
the filled region that show physiological activity and in both cases although there is clear 
motor recovery, there is still some evidence of skilled motor deficits. In the case of the 
mPFC lesion, there is partial restitution of projections (to the striatum, for example). 
There is a lack of long corticospinal axons projecting to the spinal cord, however. In 
contrast, following motor cortex lesions and FGF-2 injections, there are long projections 
from the filled region to the spinal cord, and those projections are electrophysiologically 
functional (Monfils et al., 2005b). 
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General principles emerging from these findings 
The role of FGF-2 
Evidence from a number of studies has highlighted a role of FGF-2 in both development 
and recovery from brain injury. There is also evidence suggesting that the different 
spatio-temporal developmental expression of FGF-2 might play a role in modulating 
recovery from cortical damage in neonatal rats (Ganat et al., 2002; Monfils et a l , 2005a). 
It appears, however, that the mere presence of FGF-2 is not sufficient. The FGF must be 
present at the right time and in a physiologically relevant dose. It is likely that a complex 
interaction of FGF-2 with its receptors (and in particular FGFR1) mediates the reaction of 
this ligand in response to injury (see Clarke et al., 2001). Further, endogenous and 
exogenous FGF-2 seem to be additive in their role following injury throughout early 
development and combined endogenous and exogenous FGF-2 levels may be deleterious 
if they are too high (Hastings, 2003). 
It is clear that FGF-2 plays a role in the recovery observed in a number of experimental 
conditions (Gibb & Kolb, submitted; Comeau et al., 2005; Monfils et al., 2005a, 2005b, 
2005d, 2005e; Rowntree & Kolb, 1997). What could be the underlying mechanisms by 
which FGF-2 exerts its beneficial effects? Are there mechanisms common to the 
different injuries sustained? 
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Regenerative plasticity, and degenerative plasticity 
There appears to be a qualitative difference in the changes that occur in response to 
various forms of experience. First, in some instances, changes that occur as a result of 
brain injury are associated with a beneficial functional outcome (e.g., P10 medial 
prefrontal cortex lesion). In other cases, modifications found following lesions appear to 
hinder function (e.g., P3 motor cortex lesion). A good example illustrating these 
principles is the case of bilateral vs. unilateral injury. Following focal bilateral injury 
(e.g., a motor cortex lesion), a number of changes occur in different motor areas, or in 
regions adjacent to the lesion. Those changes are considered to be regenerative. It is not 
exactly known what signals or mechanism cause these changes to occur, but we do know 
that they are associated with a positive functional outcome. In fact, inhibiting those 
changes also inhibits the improved outcome. Furthermore, when focal motor cortex 
lesions are inflicted at a time when those changes do not occur (e.g., P3), there is no 
functional improvement. Following a unilateral motor cortex lesion (at P10 or 
adulthood), the changes are different; namely, on the side contralateral to the lesion we 
see changes that are similar to those described for bilaterally-lesioned rats- regenerative 
processes. However, on the side ipsilateral to the lesion, the changes take a different 
form- we actually see a decrease on measures of dendritic morphology. Furthermore, 
tracing studies have shown that the side contralateral to the lesion extends projections to 
the regions originally subserved by the now-lesioned side (Kolb, Gibb & van der Kooy, 
1994). Here again, the precise mechanism at the source of this effect is not fully 
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understood. It is likely, however, that those plastic changes are derived from 'naturally-
occurring' events that just happen to be enhanced following an injury. 
Developmental brain plasticity 
There must be some key developmental principles involved that modulate the window of 
plasticity at different ages and different areas. There are several stages to cortical 
development; namely, cell proliferation, migration, differentiation, dendritic and axonal 
growth, synaptogenesis, gliogenesis, and synaptic pruning and cell death. Those different 
steps occur a different rates and over a different length of time in different species, but 
nevertheless show a consistent pattern. In rats, most cell proliferation is complete at 
birth, whereas migration continues for approximately one additional week (Bayer & 
Altman, 1990). Dendritic arborization, synaptogenesis, and gliogenesis reach apeak in 
the second and third weeks of development. This is important, because various types of 
experiences (including lesions and/or the presence of growth factors) have different 
effects on the brain that likely largely depend on the major developmental events that are 
occurring during that time. For example, during dendritic development and 
synaptogenesis, an increase in afferent input enhances the formation of additional 
synapses, whereas a decrease leads to synaptic pruning (e.g., Fifkova, 1970). 
Importantly, because different animals develop at different rates (and so do their brains), 
a useful way to make sense of changes that occur in response to various treatments is to 
relate any changes to the different steps that are known to occur in a number of species. 
For example, the same developmental events that take place around PI2 in the rat occur 
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around 8 months of age in humans (Kolb et al., in press). Of course, identifying how the 
brain responds to different treatments inflicted at various time points also furthers our 
knowledge of these different steps, and refines our ability to capitalize on 'naturally-
occurring' mechanisms to promote recovery. We tried to close in on the potential 
mechanisms that could explain the behavioural improvements seen in the lesioned FGF-2 
treated rats, but of course these give rise to many unanswered questions. The bottom 
line: in the treated rats, there is tissue that would not otherwise be there, and this tissue is 
functional. 
Limitations and future studies 
The design employed in the present study was such that we attempted to evaluate whether 
the filled region was involved in the recovery seen in the lesioned-FGF-2 treated rats. In 
doing so, we attempted to (1) assess the 'integrity' of the filled region using a variety of 
converging techniques, and, (2) break the relationship between the filled region and 
functional improvement. The limitations in assessing the first point were in that whereas 
we made progress in assessing the physiology, functionality, connectivity, and cellular 
make up of the filled region, we failed to isolate distinct mechanisms that could explain 
each of the steps involved in the generation and formation of the new tissue. Future 
experiments should study each of these phenomena in isolation to evaluate the 
interactions of FGF-2, P10 and motor cortex injury in modulating the various levels of 
recovery. For example, what is the role of FGF-2 in neurogenesis? What is the 
relationship of motor cortex lesion at P10 to cell migration? What is the role of FGF-2 
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signaling in promoting the extension of long descending axons to an appropriate target in 
the spinal cord? With respect to our second goal, again, we made progress in ruling out 
the role of other regions in subserving the functional recovery (indirectly testing the 
prediction that the filled region was involved), and tried to dissociate the relationship 
between function and filled region using two different experimental designs. The 
obvious problem, of course, is that neither design is without flaws: El 3 BrdU prevents 
cortical neurogenesis, but also has an overall effect on the whole brain, which in some 
respects clouds the role of the filled region in subserving recovery. The re-lesioning 
design sidesteps the problems with the BrdU experiment but (1) re-lesioning *only* the 
*new* tissue is impossible, and (2) removal of the tissue via aspiration undoubtedly 
disturbs the function of areas that were connected to the lost tissue, leading again to a 
larger functional lesion than intended. 
An important point that was not addressed in the current thesis was to attempt to 
disambiguate between the role of the filled region and the role of other areas in their 
contributions to the functional recovery. Future studies will aim to address this 
discrepancy by manipulating FGF-2 levels following P10 lesions to the motor cortex in 
the opposite direction- i.e., downregulating or blocking FGF-2. If FGF-2 is involved in 
mediating the changes that support partial recovery of function dissociated from a filling 
of the cavity in lesioned rats that do not receive FGF-2, then reducing FGF-2 levels with 
neutralizing antibodies should inhibit *the majority* of functional improvements. 
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Implications 
Some of the principles that emerged (or were emphasized) from our experiments should 
be applied to different time points, different areas, and different types of injury, in order 
to determine how our findings generalize to other ages and injuries. It is known already 
that FGF-2 does not stimulate tissue growth after P3 mPFC lesions (e.g., Comeau et al., 
2005) or after P3 motor cortex lesions (Monfils, unpublished observations). But it is not 
known if FGF-2 given after P10 lesions to more posterior regions might also stimulate 
cell growth and functional recovery. It is also not known if combinations of FGF-2 and 
experiential treatments known to influence functional recovery after perinatal injury 
might be synergistic and further enhance functional recovery after perinatal injury. 
Finally, it is not known if our results generalize to other species, and especially species 
with larger brains in which there is a longer distance from the SVZ to the site of injury. 
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Abstract 
The main objective of the present study was to perform an unbiased comparison of 
immersion vs. perfusion techniques to assess whether we could use the former to quantify 
synapses through electron microscopy. Using the immersion technique include is ideally 
suited for instances in which the specimen under study could not be perfused under the 
standard EM protocol. Our results suggest that, despite suboptimal qualitative results, 
fixation by immersion allows for adequate quantification of synapses. 
Key words: Electron microscopy, Golgi-Cox, synaptic density 
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The main objective of the present study was to perform an unbiased comparison of 
immersion vs. perfusion techniques to assess whether we could use the former to quantify 
synapses through electron microscopy (EM). The standard EM protocol involves fixation 
by perfusion. An advantage of using the immersion technique is that it is ideally suited 
for instances in which the specimen under study could not be perfused with 
Glutaraldehyde (GA) and Paraformaldehyde (PFA) (the standard EM protocol). 
Additionally, fixation by immersion would allow processing of different brain regions 
with different protocols. A relevant example from studies conducted in our laboratory is 
the Golgi-Cox method. Effectively, Golgi-Cox staining and EM both enable estimation 
of the number of excitatory synapses, however the two techniques are qualitatively 
different. Golgi-Cox impregnation permits the visualization of whole cells, including 
dendritic arborization and spines, and provides a global overview of treatment-induced 
changes (Gibb & Kolb, 1998). EM, on the other hand, provides higher resolution imaging 
of cell ultrastructure including synaptic terminals, but is limited to smaller areas of the 
brain (Bozzola & Russell, 1991). Quantification following Golgi-Cox staining can 
provide information about the complexity of the stained neurons, the length of the 
dendrites, as well as the density of dendritic spines. With EM, unbiased stereology can be 
performed on electron micrographs, enabling identification of synapse type and 
quantification of synaptic density per unit volume of tissue. 
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However, to perform Golgi-Cox and EM on the same specimens presents a challenge. 
The Golgi-Cox methodology routinely employed in our laboratory requires a saline 
perfusion (Gibb & Kolb, 1998), and in order to facilitate the penetration of Golgi-Cox 
through the tissue, aldehydes should not be included in the perfusion solution. Likewise, 
it is widely believed that, in order to yield properly preserved tissue for EM, brains 
require perfusion with glutaraldehyde (GA), either alone or in combination with 
paraformaldehyde (PFA) (Bozzola & Russell, 1991). 
The methodology outlined here is an extension of the work by Morin et al. (1997), which 
presented a technique allowing fixation of resected human tissue by immersion. We 
compared synapse quantification derived from samples processed using perfusion vs. 
immersion fixation. The latter methodology could potentially enable both EM and Golgi-
Cox procedures to be performed on different hemispheres of the same brains. The 
practical applications of using both EM and Golgi techniques in two different 
hemispheres of the same animal are discussed. 
MATERIALS AND METHODS 
Perfusion and initial fixation 
Two groups of four rats each were used in this study. All rats were deeply anesthetized 
with sodium pentobarbital (120 mg/kg) prior to perfusion. Rats from the first group, 
which served as the EM control group, were transcardially perfused with phosphate 
buffered saline (PBS) (0.9% saline in 0.1 M P 0 4 ) followed by 2% paraformaldehyde 
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(PFA)/2.5% glutaraldehyde (GA) in 0.1M PBS. The brains were then stored in 2% 
PFA/2.5% GA at 4° C until dissection of the motor cortex took place. 
Rats from the experimental group were perfused with 0.9% saline only. Each brain was 
then cut in front of the cerebellum, and mid-saggitally. One hemisphere was immersed in 
Golgi-Cox solution (see Gibb and Kolb, 1998) while the other was immersed in a 37 °C 
fixative solution containing 0.1 M cacodylate buffer, 2.5% GA, 4% PFA and 2.5% 
dimethysulfoxide (DMSO) for 5 minutes, after which it is transferred to the same fixative 
solution at a temperature of 4° C. This hemisphere was stored at 4° C for seven days and 
then dissected and processed for EM as described below. The hemisphere immersed in 
Golgi-Cox solution was processed according to methods previously described (Gibb & 
Kolb, 1998). 
EM preparation 
The control brains, as well as the hemispheres for EM from the experimental group, were 
coronally sectioned (300 um) on a vibratome, and the sections viewed under a dissecting 
microscope at low power (2X). Samples of tissue (approximately 500 urn wide) 
extending from pia to white matter were dissected from the caudal forelimb area of motor 
cortex using a sharp razor blade. The tissue blocks were then processed according to the 
methodology previously reported (Kleim et al., 1996) Briefly, the blocks were washed in 
0.1M cacodylate buffer for 2 hours, postfixed in 2% osmium tetroxide/1.5% potassium 
ferrocyanide in 0.1 M cacodylate buffer for 2 hours and en bloc stained with 2% uranyl 
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acetate for 45 min. The samples were then dehydrated through an ascending series of 
ethanol concentrations before being transferred into propylene oxide followed by gradual 
embedding in Eponate resin. 
A few (approximately 10) 1 um sections were cut from a block of embedded tissue from 
each rat. Sections were stained with toluidine blue, and cortical layer V was identified by 
the presence of large pyramidal cells and the absence of layer IV granule cells using the 
light microscope. Next, most of the block was trimmed away in a pyramidal shape, 
leaving a small strip containing layer V of the motor cortex. From this strip, silver/gray 
serial sections (approximately 70 nm thick) were cut using a diamond knife. These 
sections were collected on Formvar-coated, slotted, copper grids, and stained sequentially 
with uranyl acetate followed by lead citrate. 
Stereology 
Thin sections were surveyed with the electron microscope and an area of the neuropile 
that was essentially free of nuclei was selected in one of the serial sections. Within this 
area, a composite of four micrographs were taken at X 6,000 such that each micrograph 
represented one quadrant of a square. Next, the same area in a non-consecutive section 
(i.e. the intervening section was skipped) was photographed at the same magnification. A 
minimum of 16 micrographs were prepared for each rat. The resulting negatives were 
then printed at a final magnification of X 23,800 and subsequently analyzed for synaptic 
density using the physical dissector method (Sterio,1984). In this method, an unbiased 
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counting frame of known area (105 um 2) is placed over each micrograph of the first 
composite (reference sections) and the number of synapses counted. The same frame is 
then placed over each micrograph from the second composite (lookup sections) and 
synapses not visible in the reference section are counted. In this way, synapses are 
counted only once. In the present study, synapses were identified by the presence of 
synaptic membrane specializations and only those with at least three vesicles were 
included in the counts. From these counts, the synaptic density per volume (um 3) could 
be determined. 
RESULTS 
Golgi-Cox staining 
As shown in Figure 1, the Golgi-Cox method yielded staining of whole cells. The 
extensive staining permits observation, and quantification (not shown here), of dendritic 
branches and spines. 
EM: qualitative observations 
Except for a difference in contrast, the appearance of both control and experimental tissue 
sections was similar at low magnification (Figures 2A and 2B). Increased contrast of the 
experimental tissue sections was apparent and likely due to the extraction of cytoplasmic 
proteins during the interval between saline perfusion and infiltration of the fixative. There 
was other evidence of suboptimal preservation in the experimental tissue sections but this 
was minimal and appeared to be restricted primarily to the nuclei. As seen in Figure 2B, 
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vacuoles were apparent in some nuclei (*), however other membranes appeared normal. 
Myelin sheaths in both control and experimental tissue showed no signs of de-lamination. 
Membrane discontinuities and other indicators of inadequate fixation (Hayat, 1981), were 
not seen. The synapses, which were the primary focus of this study, also showed little 
variation between fixative regimens (Figures 2C and 2D). Post-synaptic vesicles were 
easily discernable in all tissues, although not as well preserved in the experimental group 
tissue. All of the synaptic types could be easily identified in both groups. 
Synaptic Density 
The physical disector method was performed on thin sections of both tissue groups 
(control and experimental) to determine whether there was a quantitative difference 
between synaptic densities (Sterio, 1984). The total synaptic volumes analyzed were 
250.56 um 3 and 195.16 um 3 respectively. The number of synapses per cubic micrometer 
was, on average, 0.233 for the control group and 0.278 for the experimental group 
(Figure 3). A between-subjects t-test was performed to compare the synaptic density 
between both groups, and revealed that there was no significant difference (p> 0.05). 
DISCUSSION 
The primary goal of the present study was to perform an unbiased comparison of 
immersion vs. perfusion techniques to assess whether we could use the former to quantify 
synapses. Such a design would afford the opportunity to process different portions of the 
same brains with different protocols (e.g., Golgi-Cox staining and EM), or to quantify 
synapses using EM in tissue that was not prepared using the standard perfusion protocol. 
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The Golgi-Cox methodology is a well-established analytical procedure that has been used 
extensively in our lab for over two decades. In order to extend our observations to the 
EM level and at the same time maintain consistency with previous Golgi-Cox studies, it 
was imperative that only the EM procedure be modified. The two techniques are 
qualitatively different, and because each technique affords specific information that the 
other does not, the two are complimentary. 
The protocol presented here is a modified version of Morin et al.'s (1997) methodology, 
which was originally designed to prepare resected human tissue for EM analyses. In their 
study it was determined that the addition of DMSO to the immersion fixation solution 
resulted in acceptable preparation of nervous tissue and maintenance of the structural 
integrity of synaptic elements. DMSO facilitates the penetration through the tissue, likely 
by weakening the tissue permeability barrier (Morin et al., 1997; Franz & Van Bruggen, 
1967). Inclusion of this reagent in the fixative solution is also believed to enhance 
preservation of membranes (Sandborn et al, 1975). Using this reagent, our results 
demonstrate that although some fixation artifact was apparent in the experimental group 
tissue compared to tissue of the control EM group, the synaptic complex retained its 
integrity. In fact, the increased contrast of the experimental tissue sections enhanced the 
visibility of synapses making them more easily identifiable in these sections. 
Using unbiased stereology techniques, we confirmed that there was no significant 
difference between synapse counts for the control and the experimental tissue groups, 
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thus signifying that suboptimal preservation of the experimental group tissue had no 
effect on the quantitative results. In addition, the numbers obtained in our counts 
compared favorably with those published for other studies (Kleim et al., 2004; Kleim et 
al., 2002) using the same stereological procedures on micrographs produced from tissue 
prepared using standard procedures. The generalizability of our results is limited, 
however, because we did not determine whether the fixative penetration was adequate to 
quantify synapses in deeper brain structures. 
Despite the fact that both the Golgi-Cox and EM techniques allow for the quantification 
of synapses (either directly or indirectly), we do not feel it would be appropriate to 
directly compare quantitative results obtained using each of them. Effectively, results 
using those two methodologies independently have proven, in the past, to be comparable 
in relative terms (i.e., treatments found to induce an increase in dendritic morphology as 
assessed by the Golgi-Cox method were also found to induce increases in synapses using 
EM [Juraska, 1984; Greenough et a l , 1985). The magnitude of effect and the raw 
numbers however, cannot be appropriately compared because the unit of analysis derived 
from each methodology is qualitatively different. 
Because each method confers specific advantages over the other, we believe it is 
advantageous to be able to perform both Golgi-Cox and EM procedures on the same 
animal. EM techniques are laborious and rather costly in comparison to the rapid and 
inexpensive Golgi-Cox method. We thus suggest that performing the latter technique is 
166 
the most cost-efficient way to derive an index of synaptic changes in large areas of the 
brain. Combining this technique with EM, however, enables quantitative measurements 
on targeted areas of interest. 
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Figure 1. Golgi impregnated pyramidal cell from layer III in area Pari. In A, picture of a 
golgi impregnated pyramidal cell from layer III in area Pari. In the insets (B and C), 
higher magnification (1060X) showing complete labeling of dendrites and dendritic 
spines from an apical (B) dendrite, and a basilar (A) dendrite (after Kolb et al., 2003). 
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Figure 2. Effect of perfusion (control) vs. immersion (experimental) fixation of tissue on 
ultrastructure. As can be seen in these representative micrographs, some aberrations were 
present in the experimental group (A and C), compared to the control EM group (B and 
D), including pericuclear enlargement (*), intra nuclear artifacts (#), enlarged myelin ( A ), 
and extracted ground plasm. Synapses (@) appeared to be unaltered by the experimental 
methodology. 
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Figure 3. Synaptic density in Layer V of motor cortex for the experimental and control 
EM groups. There was no difference between the experimental and control EM groups in 
the number of synapses per um3 (p> .05). 
